<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.0?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Evid Based Complement Alternat Med</journal-id><journal-id journal-id-type="iso-abbrev">Evid Based Complement Alternat Med</journal-id><journal-id journal-id-type="publisher-id">ECAM</journal-id><journal-title-group><journal-title>Evidence-based Complementary and Alternative Medicine : eCAM</journal-title></journal-title-group><issn pub-type="ppub">1741-427X</issn><issn pub-type="epub">1741-4288</issn><publisher><publisher-name>Hindawi</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7772015</article-id><article-id pub-id-type="doi">10.1155/2020/6642588</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Evaluation of Antidiabetic Activity of <italic>Ajuga integrifolia</italic> (Lamiaceae) Root Extract and Solvent Fractions in Mice</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-4051-8459</contrib-id><name><surname>Alene</surname><given-names>Molalegn</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-1315-9400</contrib-id><name><surname>Abdelwuhab</surname><given-names>Mohammedbrhan</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-5935-643X</contrib-id><name><surname>Belay</surname><given-names>Assefa</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-1218-5826</contrib-id><name><surname>Yazie</surname><given-names>Taklo Simeneh</given-names></name><email>taklosimeneh23@gmail.com</email><xref ref-type="aff" rid="I2">
<sup>2</sup>
</xref></contrib></contrib-group><aff id="I1">
<sup>1</sup>Department of Pharmacology, College of Medicine and Health Sciences, University of Gondar, P.O. Box 196, Gondar, Amhara, Ethiopia</aff><aff id="I2">
<sup>2</sup>Pharmacology Unit and Research Team, Department of Pharmacy, College of Health Sciences, Debre Tabor University, P.O. Box 272, Debre Tabor, Amhara, Ethiopia</aff><author-notes><fn fn-type="other"><p>Academic Editor: Mohammad Faisal</p></fn></author-notes><pub-date pub-type="collection"><year>2020</year></pub-date><pub-date pub-type="epub"><day>22</day><month>12</month><year>2020</year></pub-date><pub-date pub-type="pmc-release"><day>22</day><month>12</month><year>2020</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>. --><volume>2020</volume><elocation-id>6642588</elocation-id><history><date date-type="received"><day>12</day><month>11</month><year>2020</year></date><date date-type="rev-recd"><day>7</day><month>12</month><year>2020</year></date><date date-type="accepted"><day>12</day><month>12</month><year>2020</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2020 Molalegn Alene et al.</copyright-statement><copyright-year>2020</copyright-year><license xlink:href="https://creativecommons.org/licenses/by/4.0/"><license-p>This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><p>Traditional healers and the community have used the roots of <italic>Ajuga integrifolia</italic> for the treatment of diabetes mellitus. It is not scientifically validated for its antidiabetic activity previously. Therefore, the objective of the present study was to determine the hypoglycemic and antidiabetic activity of <italic>Ajuga integrifolia</italic>. <italic>Ajuga integrifolia</italic> roots' crude extract and solvent fractions were prepared. The doses of 100&#x02009;mg/kg, 200&#x02009;mg/kg, and 400&#x02009;mg/kg of crude root extract and solvent fractions were used on normoglycemic, oral glucose loaded, and streptozotocin-induced diabetic mice models to determine their hypoglycemic and antihyperglycemic activities. The crude extract and solvent fractions' effect on bodyweight was also evaluated on streptozotocin-induced diabetic mice. A standard drug in all cases was glibenclamide (5&#x02009;mg/kg), and the blood glucose level was measured by using a glucose meter. Data analysis was performed by using Statistical Package for Social Sciences version 21. One-way analysis of variance followed by Tukey's post hoc multiple comparison test was used to analyze the data. <italic>p</italic> value&#x02009;&#x0003c;&#x02009;0.05 was considered statistically significant. Hydromethanolic crude extract and its aqueous fraction of <italic>Ajuga integrifolia</italic> root showed a considerable blood glucose lowering activity at all doses. Both the repeated daily doses of the crude extract and the repeated daily doses of the aqueous fraction of <italic>Ajuga integrifolia</italic> root extract revealed the similar effect in lowering the fasting blood glucose level in streptozotocin-induced diabetic mice models. It was also found that groups treated with the <italic>Ajuga integrifolia</italic> at the doses of 200&#x02009;mg/kg and 400&#x02009;mg/kg showed significant (<italic>p</italic> &#x0003c; 0.05) bodyweight improvement at the 14<sup>th</sup> day of treatment compared to the respective baseline bodyweight, and the diabetic control group showed significant (<italic>p</italic> &#x0003c; 0.01) reduction in bodyweight at the 14<sup>th</sup> day compared to the baseline. This study revealed that crude extract and solvent fractions of <italic>Ajuga integrifolia</italic> root possess significant antidiabetic activity which supports its traditional use for the treatment of diabetes mellitus.</p></abstract><funding-group><award-group><funding-source>University of Gondar</funding-source></award-group></funding-group></article-meta></front><body><sec id="sec1"><title>1. Background</title><p>Diabetes mellitus (DM) is a cluster of metabolic diseases occurred as a result of insulin deficiency, insulin resistance, or both that result in hyperglycemia [<xref rid="B1" ref-type="bibr">1</xref>]. Long-term damage and failure of the eyes, kidneys, nerves, heart, and blood vessels were evident in chronic hyperglycemia [<xref rid="B2" ref-type="bibr">2</xref>]. Development of DM involves different pathogenic processes, and these range from autoimmune destruction of the pancreatic <italic>&#x003b2;</italic>-cells that result in absolute insulin deficiency to abnormalities that result in insulin resistance. The basis of the abnormalities in the metabolism of carbohydrate, fat, and protein in diabetes is insufficient action of insulin on target tissues [<xref rid="B3" ref-type="bibr">3</xref>, <xref rid="B4" ref-type="bibr">4</xref>]. The projected number of people aged 20&#x02013;79 years with diabetes was 463 million worldwide in 2019. The worldwide prevalence of DM is estimated to rise to 578 million in 2030. The prevalence of diabetes in this age group was expected to be increased by 143% in Africa from 2019 to 2045, which is higher than other parts of the world. Diabetes and its complications caused significant deaths which are estimated to be 4.2 million in 2019. The annual worldwide health cost on diabetes is estimated to be United States Dollar (USD) 760 billion. It is expected that cost will be USD 825 billion by 2030 and USD 845 billion by 2045 [<xref rid="B5" ref-type="bibr">5</xref>].</p><p>Management of DM includes diet modification, exercise, weight loss, oral hypoglycemic agents, and insulin; however, none of them can treat the underlying cause of the disease nor can they cure the illness consequently [<xref rid="B2" ref-type="bibr">2</xref>, <xref rid="B3" ref-type="bibr">3</xref>, <xref rid="B6" ref-type="bibr">6</xref>]. The limitation of currently available drugs in terms of safety, efficacy, and cost warrants the development of new antidiabetic drugs from plant-derived compounds which are more efficacious, safer, and easily accessible [<xref rid="B2" ref-type="bibr">2</xref>, <xref rid="B5" ref-type="bibr">5</xref>]. Worldwide, more than 1000 plants have been known as efficacious in the treatment of DM. However, fewer than half of these plants or plant extracts have been scientifically validated for their claimed use [<xref rid="B7" ref-type="bibr">7</xref>, <xref rid="B8" ref-type="bibr">8</xref>]. Lamiaceae is one of the plant families that have hypoglycemic activity. <italic>Ajuga integrifolia</italic> is an herb belonging to Lamiaceae family under genus <italic>Ajuga</italic> and is locally known as &#x0201c;Tut Astel&#x0201d; and &#x0201c;Akorarach&#x0201d; in Amharic and &#x0201c;Harmegusa&#x0201d; in Oromifa in various parts of Ethiopia [<xref rid="B9" ref-type="bibr">9</xref>&#x02013;<xref rid="B11" ref-type="bibr">11</xref>]. In Ethiopia, <italic>Ajuga integrifolia</italic> occurs in different regions including Amhara, Southern Nation, Nationalities and People (SNNP), Tigray, and Oromia [<xref rid="B12" ref-type="bibr">12</xref>]. The aqueous and occasionally alcohol infusion of the fresh or dried leaves or root of the <italic>Ajuga integrifolia</italic> are traditionally used for treating DM [<xref rid="B13" ref-type="bibr">13</xref>].</p><p>Antioxidants are known to prevent oxidative stress, thereby treating DM and its complications [<xref rid="B14" ref-type="bibr">14</xref>&#x02013;<xref rid="B16" ref-type="bibr">16</xref>]. <italic>Ajuga integrifolia</italic> was confirmed to have well-established in vitro antioxidant activities and had inhibitory concentration, IC50 value of about 18.9 [<xref rid="B17" ref-type="bibr">17</xref>], giving hint the plant may have antidiabetic activity. It was screened phytochemically and reported that terpenoides, glycosides, tannins, flavonoids, alkaloids, steroids, phenols, and saponins were most commonly isolated biologically active principles responsible for its medicinal properties [<xref rid="B13" ref-type="bibr">13</xref>]. In addition, the roots of <italic>Ajuga integrifolia</italic> have larger amounts of chromium which may be correlated to its use as treatment for DM [<xref rid="B18" ref-type="bibr">18</xref>]. Thus, the present study was performed to determine the antidiabetic activity of the root extract and solvent fraction of <italic>Ajuga integrifolia</italic> in mice.</p></sec><sec id="sec2"><title>2. Materials and Methods</title><sec id="sec2.1"><title>2.1. Drugs, Chemicals, and Instruments</title><p>Drugs and chemicals used in the study were streptozotocin (Sigma Aldrich, Germany), methanol absolute (Nice Chemical, India), glibenclamide (Julphar pharmaceutical, Ethiopia), trisodium citrate dehydrate (Blulux Laboratories, India), citric acid monohydrate (Lab Tech chemical, India), 40% glucose solution (Reyoung Pharmaceutical, China), sterilized water for injections (Nirman Ltd., India), and distilled water, whereas the instruments used in this study were analytical balance, pH meter, glucometer and test strips (Alliance international, Taiwan), beakers, Whatman filter paper No.1, funnels, glass rod, measuring cylinder, vacuum pump, spatula, pipettes, gavage (oral feeding syringe), animal cages, insulin syringe with needle, oven, and desiccators. Analytical grade drugs, chemicals, and instruments were used.</p></sec><sec id="sec2.2"><title>2.2. Collection of Plant Material</title><p>Fresh root of <italic>Ajuga integrifolia</italic> was collected from Gondar town in North Gondar, North Ethiopia. The botanical identification and authentication of the plant material was performed by a botanist, and voucher specimens (MA001/2019) were deposited in Herbarium of Biology Department, Faculty of Natural and Computational Science, University of Gondar.</p></sec><sec id="sec2.3"><title>2.3. Preparation of Plant Crude Extract and Fractionation</title><p>The dirt and particulate matter was removed from the root of <italic>Ajuga integrifolia</italic> by washing rigorously with distilled water. Then, root of <italic>Ajuga integrifolia</italic> was dried under shade at room temperature (20&#x02013;30&#x000b0;C) with most favorable ventilation. The dried roots of the plant were pulverized into coarse powder by an appropriate electrical miller. The coarse powdered roots of the plant were macerated in 80% methanol in a ratio of 750&#x02009;g of sample material: 7.5 liters of solvent (w/v) separately. Then, the extract was filtered by using gauze followed by Whatman filter paper No. 1. The marc was remacerated two times with fresh solvent (80% methanol), each for 3 days, and the filtrates so obtained from the sequential macerations were allowed to concentrate removing the methanol solvent by a rotavapor followed by drying in an oven with a temperature of not greater than 40&#x000b0;C, and the aqueous part was removed by lyophilization under reduced pressure. Then, the remaining solvent free extract was kept alone in a desiccator till it was used for the study and the fractionation process in case the extract could contain hygroscopic element.</p><p>About 164&#x02009;g out of 750&#x02009;g sample was harvested following extraction with an extractive yield of 21.9%. For fractionation, 100&#x02009;g of methanol crude extract was suspended in a separatory funnel with 400&#x02009;ml of distilled water. Then, the suspension was shaken by adding 400&#x02009;ml volume of <italic>n</italic>-hexane. Then, the <italic>n</italic>-hexane layer so formed was poured into a beaker and labeled as &#x0201c;<italic>n</italic>-hexane fraction.&#x0201d; The aqueous remainder was again mixed with same quantity of chloroform and shaken similarly, and the chloroform layer obtained was decanted to a second beaker and labeled as &#x0201c;chloroform fraction&#x0201d; likewise. The remaining aqueous residue was lyophilized to obtain pure aqueous fraction, placed in a third beaker and labeled as &#x0201c;aqueous fraction,&#x0201d; and the <italic>n</italic>-hexane and chloroform fractions were allowed to concentrate in an oven under a temperature set at 40&#x000b0;C. Finally, 12&#x02009;g hexane and 17&#x02009;g of chloroform fractions and 2&#x02009;g of oleaginous jelly matter were obtained with the remaining 69&#x02009;g being aqueous fraction. All fractions were put in an amber bottle and stored in a fridge till they were going to be used for the experiment.</p></sec><sec id="sec2.4"><title>2.4. Experimental Animals</title><p>Swiss albino male mice which were healthy weighed 20&#x02013;30&#x02009;g and aged 8&#x02013;12 weeks were used in the study, and healthy female mice having similar weight and age to males were used for the acute oral toxicity study. The mice used for the study were acquired from the Ethiopian Public Health Institute. The mice were stayed in light and dark cycle (12 hours of each cycle) which is a standard condition for laboratory animals and permitted open access to standard pellet diet and water ad libitum. Acclimatization of the mice to the laboratory conditions was performed for 1 week prior to the start of the experiment.</p></sec><sec id="sec2.5"><title>2.5. Acute Oral Toxicity Study</title><p>According to the limit test of OECD No. 425 guideline, the acute oral toxicity test was performed [<xref rid="B19" ref-type="bibr">19</xref>]. One female Swiss albino mouse was fasted for 4 hours in the first day of the test. Then, 2&#x02009;g/kg of the extract was administered via mouth and was observed rigorously for physical or behavioral changes for one day with special consideration during the first 4 hours. According to the results of the first mouse, another four female mice were recruited and fasted for 4 hours and then given a single dose of 2&#x02009;g/kg and was observed rigorously in the same manner. A total of 2 weeks was used to observe for development of any signs of toxicity [<xref rid="B20" ref-type="bibr">20</xref>]. According to the result of the acute oral toxicity study, the lower, medium, and high doses of the plant extracts were determined.</p></sec><sec id="sec2.6"><title>2.6. Grouping and Dosing of Mice</title><p>Male mice were used in all mice models (normoglycemic, oral glucose loaded, one dose treated diabetic, and repeated dose treated diabetic mice) because female mice are less sensitive to insulin [<xref rid="B21" ref-type="bibr">21</xref>] and STZ compared to male mice [<xref rid="B20" ref-type="bibr">20</xref>, <xref rid="B22" ref-type="bibr">22</xref>]. Mice were randomly divided into five groups (6 mice per group) in the normoglycemic, oral glucose loaded, and one dose treated diabetic mice models. Working to the all cases, group 1 used as negative control was treated with 10&#x02009;ml/kg distilled water (DW). Experimental groups 2, 3, and 4 received 100&#x02009;mg/kg, 200&#x02009;mg/kg, and 400&#x02009;mg/kg root extract of the plant, respectively, whereas group 5 used as positive control was treated with glibenclamide (GLC) 5&#x02009;mg/kg, which was a standard drug. In single dose of the three solvent root fraction treated diabetic mice model, mice were randomly divided into 11 groups (each group comprised 6 mice). Group 1 (negative control) was treated with 10&#x02009;ml/kg DW; the 9 experimental groups received solvent fraction of the root extract of the plant (groups 2, 3, and 4 received three different doses of aqueous fraction of the root extract of the plant; groups 5, 6, and 7 received three different doses of <italic>n</italic>-hexane fraction of the root extract of the plant; and groups 8, 9, and 10 received three different doses of chloroform fraction of the root extract of the plant). Group 11 received 5&#x02009;mg/kg GLC. GLC was used as a standard drug on basis of previous reports on earlier literatures [<xref rid="B23" ref-type="bibr">23</xref>, <xref rid="B24" ref-type="bibr">24</xref>].</p><p>In repeated daily doses treated diabetic mice, mice were randomly divided into six groups (5 groups of diabetic mice and 1 another group of normal mice, each group comprised of 6 mice). Group 1 was diabetic control treated with 10&#x02009;ml/kg DW; doses of 100&#x02009;mg/kg, 200&#x02009;mg/kg, and 400&#x02009;mg/kg root extract of plant were given to experimental groups 2, 3, and 4, respectively; group 5 was diabetic positive control treated with 5&#x02009;mg/kg glibenclamide, whereas group 6 was normal control treated with 10&#x02009;ml/kg DW.</p></sec><sec id="sec2.7"><title>2.7. Measurement of Blood Glucose Level</title><p>Blood samples were taken from the tail vein of each mouse by cutting the tip of the tail aseptically in all mice models. Blood glucose level (BGL) was measured by the i-QARE DSW Taiwan glucometer, and measurement was carried out in triplicates so that the average value could be taken. And the reduction of the blood glucose level in percentage was calculated via the following formula: (G<sub>b</sub>&#x02009;&#x02212;&#x02009;Gp)/G<sub>b</sub>&#x02009;&#x000d7;&#x02009;100, where G<sub>b</sub> is the BGL at 0&#x02009;hr (baseline blood glucose level), and Gp is the blood glucose level after treatment.</p></sec><sec id="sec2.8"><title>2.8. Induction of Experimental Diabetes Mellitus</title><p>Inductions of diabetes were performed by using streptozotocin (STZ). First, STZ was dissolved in 0.1&#x02009;M cold citrate buffer (pH&#x02009;=&#x02009;4.5). Dose of 150&#x02009;mg/kg of the freshly prepared solution was administered intraperitoneally to 16&#x02009;hr fasted mice. After &#x000bd;&#x02009;hr of STZ administration, food and water were permitted freely to the mice. After 6&#x02009;h of STZ administration, solution of 5% glucose in a quantity of 1&#x02009;ml/kg was given to the mice for the next 24&#x02009;hr to prevent death resulting from hypoglycemic shock. Mice were screened for diabetes after 3 days of STZ injection, and fasting BGL&#x02009;&#x0003e;&#x02009;200&#x02009;mg/dl was included in the study as diabetic mice [<xref rid="B25" ref-type="bibr">25</xref>, <xref rid="B26" ref-type="bibr">26</xref>]. Then, instantly, STZ-induced diabetic mice were assigned randomly into different groups to carry out the experiment. For the maintenance of dry bedding for polyuric diabetic mice, bedding of the cages was changed every 24&#x02009;hr after STZ injection.</p></sec><sec id="sec2.9"><title>2.9. Evaluation of Hypoglycemic Activity of <italic>Ajuga integrifolia</italic> Root Crude Extract in Normoglycemic Mice</title><p>Mice fasted for about 16&#x02009;hr were divided into 5 different groups (each group comprised of 6 mice) at random. For each mouse, baseline BGL was determined prior to treatment (at 0&#x02009;hr). Then, each mouse's BGL was determined at 1&#x02009;hr, 2&#x02009;hr, 4&#x02009;hr, and 6&#x02009;hr posttreatment [<xref rid="B23" ref-type="bibr">23</xref>, <xref rid="B24" ref-type="bibr">24</xref>].</p></sec><sec id="sec2.10"><title>2.10. Evaluation of the Activity of the Crude Extract of <italic>Ajuga integrifolia</italic> Root Extract on Oral Glucose Tolerance in Normoglycemic Mice</title><p>Overnight fasted mice were divided into 5 groups (6 mice in each group) at random. Next, group 1 received 10&#x02009;ml/kg DW; groups 2, 3, and 4 were treated with hydromethanolic root extract of the plant of 100&#x02009;mg/kg, 200&#x02009;mg/kg, and 400&#x02009;mg/kg, respectively, whereas group 5 received 5&#x02009;mg/kg GLC. Following 30 minutes of after crude extracts, standard drugs, and DW administration, each mouse was fed with 2&#x02009;g/kg solution of 40% glucose in a quantity of 1&#x02009;ml/kg. Each mouse's BGL was measured prior to treatment (at 0 minute) as baseline, and then, at 1/2&#x02009;hr, 1&#x02009;hr, and 2&#x02009;hr after glucose administration [<xref rid="B24" ref-type="bibr">24</xref>, <xref rid="B27" ref-type="bibr">27</xref>, <xref rid="B28" ref-type="bibr">28</xref>].</p></sec><sec id="sec2.11"><title>2.11. Evaluation of Antihyperglycemic Activity of Single Dose of the Extract in STZ-Induced Diabetic Mice</title><p>Overnight fasted diabetic mice were arranged into 5 groups (each group comprised of 6 mice) at random. Next, mice were given DW, root crude extract of the plant, and GLC according to grouping stated above. BGL was determined prior to the starting of treatment (at 0&#x02009;hr) as baseline, and then, following treatment at 2&#x02009;hr, 4&#x02009;hr, 6&#x02009;hr, and 8&#x02009;hr.</p></sec><sec id="sec2.12"><title>2.12. Evaluation of Antihyperglycemic Activity and the Effect on Bodyweight of Repeated Daily Doses of Extract on STZ-Induced Diabetic Mice</title><p>Overnight fasted STZ-induced diabetic mice and normal mice were grouped into 6 groups (5 groups of mice having diabetes and 1 group of normal mice, 6 mice in each group) at random. The diabetic control and normal controls were given 10&#x02009;ml/kg DW; three different doses of root extract were given to diabetic treatment groups, whereas the diabetic positive control group received 5&#x02009;mg/kg GLC all dosed once daily for 14 days. BGL and bodyweight of the mice were determined prior to starting treatment on the 1<sup>st</sup> day (baseline), 7<sup>th</sup> day, and 14<sup>th</sup> day [<xref rid="B27" ref-type="bibr">27</xref>, <xref rid="B28" ref-type="bibr">28</xref>].</p></sec><sec id="sec2.13"><title>2.13. Evaluation of Antihyperglycemic Activity of Single Dose of Aqueous, Chloroform, and Hexane Fractions of Extract in STZ-Induced Diabetic Mice</title><p>After overnight fasting, mice were divided into eleven groups (<italic>n</italic>&#x02009;=&#x02009;6) at random: group 1 serving as the diabetic control group receiving 10&#x02009;ml/kg DW, group 2 receiving aqueous fraction 100&#x02009;mg/kg of AIRE, group 3 receiving aqueous fraction 200&#x02009;mg/kg of AIRE, group 4 receiving aqueous fraction 400&#x02009;mg/kg of AIRE, group 5 receiving hexane fraction 100&#x02009;mg/kg of AIRE, group 6 receiving hexane fraction 200&#x02009;mg/kg of AIRE, group 7 receiving hexane fraction 400&#x02009;mg/kg of AIRE, group 8 receiving chloroform fraction 100&#x02009;mg/kg of AIRE, group 9 receiving chloroform fraction 200&#x02009;mg/kg of AIRE, group 10 receiving chloroform fraction 400&#x02009;mg/kg of AIRE, and group 11 receiving GLC 5&#x02009;mg/kg, and BGL of every mouse was determined at 0&#x02009;hr, 2&#x02009;hr, 4&#x02009;hr, 6&#x02009;hr, and 8&#x02009;hr of AIRE fractions administration.</p></sec><sec id="sec2.14"><title>2.14. Evaluation of Antihyperglycemic Activity and the Effect on Bodyweight of Repeated Daily Doses of Aqueous Fraction of Extract in STZ-Induced Diabetic Mice</title><p>Overnight fasted STZ-induced diabetic mice were grouped into 6 groups (6 mice per groups) at random. Then, group 1 used as diabetic control received 10&#x02009;ml/kg DW; groups 2, 3, and 4 used as diabetic test groups received three doses of aqueous fraction (100&#x02009;mg/kg, 200&#x02009;mg/kg, and 400&#x02009;mg/kg, respectively); group 5 diabetic positive control was treated with 5&#x02009;mg/kg GLC, and group 6 normal control was treated with 10&#x02009;ml/kg DW once daily for 14 days. At baseline, BGL and bodyweight of the mice were determined prior to starting treatment on the 1<sup>st</sup> day of treatment (three days after STZ injection) and after that on 7<sup>th</sup> day and 14<sup>th</sup> day [<xref rid="B24" ref-type="bibr">24</xref>].</p></sec><sec id="sec2.15"><title>2.15. Ethical Consideration</title><p>This study was performed in accordance with the recommendation for the care and use of laboratory animals [<xref rid="B28" ref-type="bibr">28</xref>]. The protocol of the study was approved by the Research and Ethics Committee of Department of Pharmacology, School of pharmacy, University of Gondar, prior to commencing the study with reference number (school of pharmacy 12-112-2012).</p></sec><sec id="sec2.16"><title>2.16. Statistical Analysis</title><p>The data were presented as mean&#x02009;&#x000b1;&#x02009;standard error of the mean (M&#x02009;&#x000b1;&#x02009;SEM). One-way ANOVA followed by Tukey's post hoc multiple comparison test was used to compare means of all parameters among groups and within groups. <italic>p</italic> values&#x02009;&#x0003c;0.05 were set as statistically significant. SPSS version 21 software was used to do statistical analysis.</p></sec></sec><sec id="sec3"><title>3. Results</title><sec id="sec3.1"><title>3.1. Percentage Yield of Plant Material Extraction</title><p>From 750&#x02009;g of the plant material used for extraction, 164&#x02009;g of dried grey extract was collected after completing the extraction process with a percentage yield of about 21.9% w/w. The extract was more appreciably soluble in water than in organic solvent producing yields of hexane (12%), chloroform (17%), aqueous (69%), and remaining olegenous residue (2%).</p></sec><sec id="sec3.2"><title>3.2. Acute Oral Toxicity Study</title><p>In the acute toxicity study of <italic>Ajuga integrifolia</italic> root extract (AIRE) at the limit dose of 2000&#x02009;mg/kg, mortality of mice and any signs of toxicity (behavioral, neurological, autonomic, or physical changes) did not occur during the first day as well as throughout the course of the study. Thus, the median lethal dose (LD50) of the AIRE can be considered as more than 2000&#x02009;mg/kg.</p></sec><sec id="sec3.3"><title>3.3. Hypoglycemic Activity of the Hydromethanolic Root Extract in Normoglycemic Mice</title><p>Between groups analysis showed no significant difference in baseline fasting BGL throughout groups. Although 100&#x02009;mg/kg, 200&#x02009;mg/kg, and 400&#x02009;mg/kg AIRE reduced BGL at 4<sup>th</sup>&#x02009;hr and 6<sup>th</sup>&#x02009;hr compared to their baseline values, this reduction was not a significant reduction in the three groups given different doses of AIRE at all time points. GLC 5&#x02009;mg/kg, however, reduced BGL more significantly at 2<sup>nd</sup>&#x02009;hr, 4<sup>th</sup>&#x02009;hr, and 6<sup>th</sup>&#x02009;hr compared to each groups (negative control, three test groups with three different doses of AIRE) and baseline value. In general, a significant difference in BGL was not found when groups that received different doses of AIRE were compared with each other at all time points (<xref rid="tab1" ref-type="table">Table 1</xref>).</p></sec><sec id="sec3.4"><title>3.4. Effect of <italic>Ajuga integrifolia</italic> Root Crude Extract on Oral Glucose Tolerance in Normoglycemic Mice</title><p>Significant difference in baseline BGL was not found throughout groups prior to the start of DW, AIRE, and GLC administration (<xref rid="tab2" ref-type="table">Table 2</xref>). Between groups analysis revealed that 200&#x02009;mg/kg and 400&#x02009;mg/kg AIRE significantly decreased hyperglycemia at the 2<sup>nd</sup>&#x02009;hr compared to the BGL at 30 minutes and the negative control group, whereas 5&#x02009;mg/kg GLC showed a significant reduction of hyperglycemia at 1<sup>st</sup>&#x02009;hr and 2<sup>nd</sup>&#x02009;hr of glucose administration compared to the negative control group and 100&#x02009;mg/kg, 200&#x02009;mg/kg, and 400&#x02009;mg/kg AIRE-treated groups. A mouse receiving 400&#x02009;mg/kg crude root extract showed a statistically significant reduction in BGL at 2<sup>nd</sup>&#x02009;hr compared to 100&#x02009;mg/kg and 200&#x02009;mg/kg treated groups. Within groups analysis revealed that oral glucose loading caused a statistically significant increment in BGL after 30 minutes in all groups compared to the baseline fasting BGL regardless of the treatments given. Besides, in all groups including the negative control, there was a significant reduction in BGL at 60 and 120 minutes when compared to the respective BGL at 30 minutes after glucose administration. At 120 minutes, all AIRE-treated groups showed blood glucose reduction to a level comparable to their respective baseline values.</p></sec><sec id="sec3.5"><title>3.5. Antihyperglycemic Activity of Single Dose of <italic>Ajuga integrifolia</italic> Crude Root Extract in STZ-Induced Diabetic Mice</title><p>Between and within group analysis were performed to notice difference in BGL throughout various groups and time points, respectively (<xref rid="tab3" ref-type="table">Table 3</xref>). Significant difference in baseline fasting BGL was not observed throughout all groups. Likewise, a significant reduction in fasting BGL was not noticed in all AIRE received groups compared to the GLC-treated groups at all time points. When AIRE-treated groups were compared to the negative control, they did not show a statistically significant reduction in BGL at all time points except at the 8<sup>th</sup> hour. There was a significant reduction of BGL in 200&#x02009;mg/kg and 400&#x02009;mg/kg AIRE received groups at 8<sup>th</sup>&#x02009;hr compared to the 100&#x02009;mg/kg AIRE received group when within a group comparison was performed. The reduction of fasting BGL in percentage was recorded as 15.14% in 100&#x02009;mg/kg, 15.8% in 200&#x02009;mg/kg, and 20% in 400&#x02009;mg/kg AIRE at the 8<sup>th</sup>&#x02009;hr compared to the respective baseline fasting BGL. GLC 5&#x02009;mg/kg reduced BGL significantly at 2<sup>nd</sup>&#x02009;hr (<italic>p</italic> &#x0003c; 0.01), 4<sup>th</sup>&#x02009;hr (<italic>p</italic> &#x0003c; 0.001), 6<sup>th</sup>&#x02009;hr (<italic>p</italic> &#x0003c; 0.001), and 8<sup>th</sup>&#x02009;hr (<italic>p</italic> &#x0003c; 0.001) compared to the respective baselines.</p></sec><sec id="sec3.6"><title>3.6. Antihyperglycemic Activity of Repeated Daily Doses of Crude Extract of <italic>Ajuga integrifolia</italic> Root in STZ-Induced Diabetic Mice</title><p>Within groups' analysis of data revealed that fasting BGL was reduced in groups that received crude extract compared to the respective baseline values at all time points. The doses of 100&#x02009;mg/kg, 200&#x02009;mg/kg, and 400&#x02009;mg/kg AIRE reduced fasting BGL with a magnitude of 16.10%, 21.6%, and 26.4% after 7<sup>th</sup> day of treatment and 18.5%, 24.6%, and 28.8% after 14<sup>th</sup> day of treatment compared to the respective baseline BGL. The fasting BGL of the diabetic control was increased on the 7<sup>th</sup> day and 14<sup>th</sup> day of treatment compared to the baseline value. The fasting BGL of the normal control groups, however, did not exhibit remarkable change throughout the study period. Fasting BGL was significantly reduced in the group that received GLC (<italic>p</italic> &#x0003c; 0.01) at 7<sup>th</sup> day and (<italic>p</italic> &#x0003c; 0.001) at 14<sup>th</sup> day with percentage reduction of about 60.80% and 65% at the 7<sup>th</sup> day and 14<sup>th</sup> day of treatment, respectively, compared to the baseline values. Between groups analysis discovered that groups that received different doses of AIRE revealed a significant reduction in fasting BGL compared to the diabetic control group at the 7<sup>th</sup> day and 14<sup>th</sup> day of treatments, and treatment with GLC showed that there was a significant reduction in fasting BGL (<italic>p</italic> &#x0003c; 0.01) at 7<sup>th</sup> day and (<italic>p</italic> &#x0003c; 0.001) at 14<sup>th</sup> day compared to the diabetic control group. When GLC-treated groups were compared with the different extract dose treated groups, there was a significant reduction in the GLC-treated group (<italic>p</italic> &#x0003c; 0.05) compared to 200&#x02009;mg/kg and 400&#x02009;mg/kg AIRE, <italic>p</italic> &#x0003c; 0.01 compared to 100&#x02009;mg/kg AIRE at the 7<sup>th</sup> day and 14<sup>th</sup> day, and <italic>p</italic> &#x0003c; 0.001 compared to diabetic control (<xref rid="tab4" ref-type="table">Table 4</xref>).</p></sec><sec id="sec3.7"><title>3.7. Effect of the Repeated Daily Doses of the <italic>Ajuga integrifolia</italic> Root Crude Extract on Bodyweight of STZ-Induced Diabetic Mice</title><p>In comparison to the normal control, STZ caused a significant loss of bodyweight in the diabetic control at 7<sup>th</sup> day and 14<sup>th</sup> day of treatment. According to between groups analysis, it was observed that 100&#x02009;mg/kg AIRE did not improve bodyweight at the7<sup>th</sup> day and14<sup>th</sup> day of treatment compared to the diabetic control, but at 200&#x02009;mg/kg and 400&#x02009;mg/kg, AIRE improved significantly the bodyweight of the mice (<italic>p</italic> &#x0003c; 0.05) at the 7<sup>th</sup> day and (<italic>p</italic> &#x0003c; 0.01) at the 14<sup>th</sup> day of treatment compared to the diabetic control. The AIRE at these doses improved bodyweight significantly (<italic>p</italic> &#x0003c; 0.01) at 7<sup>th</sup> day and <italic>p</italic> &#x0003c; 0.001) at 14<sup>th</sup> day compared to the respective baseline. In comparison to the diabetic control, GLC significantly improved the bodyweight loss of STZ-induced diabetic mice at 7<sup>th</sup> day and 14<sup>th</sup> day of treatment (<xref rid="tab5" ref-type="table">Table 5</xref>).</p></sec><sec id="sec3.8"><title>3.8. Antihyperglycemic Activity of Single Doses of Three Fractions in STZ-Induced Diabetic Mice</title><p>When within group analysis was performed, the difference in reduction of fasting BGL was not significant at all time points compared to both the diabetic control and the respective baseline values of all fractions. The reduction of fasting BGL in the GLC-treated group was significant (<italic>p</italic> &#x0003c; 0.05), with a reduction of 24.19%, 37.8%, 48.4%, and 65.2% at the 2<sup>nd</sup>&#x02009;hr, 4<sup>th</sup>&#x02009;hr, 6<sup>th</sup>&#x02009;hr, and 8<sup>th</sup>&#x02009;hr compared to their baseline values. It reduced fasting BGL considerably at these time points compared to the diabetic control as well. Between groups analysis revealed that aqueous fraction of <italic>Ajuga integrifolia</italic> at 200&#x02009;mg/kg and 400&#x02009;mg/kg showed virtually significant (<italic>p</italic> &#x0003c; 0.05) reduction in BGL by decreasing with 16.8% and 21.10% at the 8<sup>th</sup>&#x02009;hr compared to hexane and chloroform fractions of the same dose. Compared to both the baseline and negative control values, the doses of 100&#x02009;mg/kg, 200&#x02009;mg/kg, and 400&#x02009;mg/kg chloroform and <italic>n</italic>-hexane fractions revealed no significant difference in BGL (<xref rid="tab6" ref-type="table">Table 6</xref>).</p></sec><sec id="sec3.9"><title>3.9. Antihyperglycemic Activity of Repeated Daily Doses of Aqueous Fraction of AIRE in STZ-Induced Diabetic Mice</title><p>According to between groups' analysis, groups treated with repeated daily doses of aqueous fractions of 100, 200, and 400&#x02009;mg/kg AIRE resulted in a considerable BGL reduction at the 7<sup>th</sup> day and 14<sup>th</sup> day compared to their baseline values (<xref rid="tab7" ref-type="table">Table 7</xref>). Moreover, there was a statistically significant (<italic>p</italic> &#x0003c; 0.01) and (<italic>p</italic> &#x0003c; 0.001) reduction of BGL in the GLC-treated group at 7<sup>th</sup> day and 14<sup>th</sup> day, respectively, compared to baseline values with around 61.30% and 64.10% reduction, respectively.</p><p>Significant reduction in BGL was observed in the GLC received group at 7<sup>th</sup> day and 14<sup>th</sup> day compared to the diabetic control, and also, BGL was reduced dramatically compared to 100&#x02009;mg/kg, 200&#x02009;mg/kg, and 400&#x02009;mg/kg aqueous fraction at the 7<sup>th</sup> day and 14<sup>th</sup> day. The AIRE 200&#x02009;mg/kg and 400&#x02009;mg/kg reduced fasting BGL significantly at the 7<sup>th</sup> day and 14<sup>th</sup> day compared to the baseline value. Fasting BGL was reduced significantly at doses of 200&#x02009;mg/kg and 400&#x02009;mg/kg aqueous fraction of AIR at 7<sup>th</sup> day and 14<sup>th</sup> day compared to the 100&#x02009;mg/kg treated group and the diabetic control (<xref rid="tab7" ref-type="table">Table 7</xref>).</p></sec><sec id="sec3.10"><title>3.10. Effect of Repeated Daily Doses of Aqueous Fraction of AIRE on Bodyweight of STZ-Induced Diabetic Mice</title><p>Significant increase in bodyweight was not noticed in mice treated with each of the three doses of aqueous fraction of AIRE at 7<sup>th</sup> day and 14<sup>th</sup> day of treatment compared to their baseline bodyweight in within group comparison (<xref rid="tab8" ref-type="table">Table 8</xref>). Comparison within the group showed that the GLC-treated group increased bodyweight only slightly on the 14<sup>th</sup> day of treatment. Bodyweight of mice received 200&#x02009;mg/kg and 400&#x02009;mg/kg aqueous fraction but not 100&#x02009;mg/kg was considerably improved at 7<sup>th</sup> day and 14<sup>th</sup> day, with percentage increment of 4.95% and 6.32%, respectively, compared to the baseline. There was no significant change in bodyweight of the normal control compared to its baseline weights.</p><p>Bodyweight loss of the diabetic control group was significant at 7<sup>th</sup> day and 14th day, with percentage decrement of 12% and 19.6% compared to the corresponding baseline bodyweight, respectively. Between groups analysis depicted that bodyweight loss of the diabetic control mice was significant at 7<sup>th</sup> day and 14<sup>th</sup> day compared to the aqueous fraction treated groups, normal control group, and GLC-treated group (<xref rid="tab8" ref-type="table">Table 8</xref>).</p></sec></sec><sec id="sec4"><title>4. Discussion</title><p>Diabetes mellitus, being a major global health threat nowadays [<xref rid="B29" ref-type="bibr">29</xref>], is seeking for studies to discover new therapeutic agents from various origins. Medicinal plants are among the most common sources and mainstay options of medicines for about 75&#x02013;80% of world population [<xref rid="B30" ref-type="bibr">30</xref>]. In the use of synthetic medicines for the treatment of various diseases, free radicals are often generated in the body which may result in an additional disease. Free radical mediated reactions are terminated by plants and drugs of plant origin that have abundant antioxidants, thereby preventing the body from oxidative damage and stress [<xref rid="B30" ref-type="bibr">30</xref>&#x02013;<xref rid="B32" ref-type="bibr">32</xref>]. The antidiabetic activity of hydromethanolic root extract and solvent fractions of <italic>Ajuga integrifolia</italic> root was evaluated in a variety of animal models. In the acute oral toxicity study at the limit dose of 2000&#x02009;mg/kg <italic>Ajuga integrifolia</italic> root extract, mortality of mice was not seen during the study period. This safety profile is consistent with a report by Tafese et al. and with the toxicity study of leaf extract of the same plant [<xref rid="B24" ref-type="bibr">24</xref>]. Therefore, the oral median lethal dose (LD50) of the AIRE can be considered to be more than 2000&#x02009;mg/kg. No toxicity incidences have been reported related to <italic>Ajuga integrifolia</italic> in particular and the genus <italic>Ajuga</italic> in general so far [<xref rid="B24" ref-type="bibr">24</xref>, <xref rid="B33" ref-type="bibr">33</xref>&#x02013;<xref rid="B35" ref-type="bibr">35</xref>].</p><p>Induction of diabetes mellitus is most commonly performed by using STZ due to its higher inductive rate and selectivity. It causes pancreatic <italic>&#x003b2;</italic>-cell destruction via DNA alkylation and strand breakage, thereby causing diabetes mellitus [<xref rid="B36" ref-type="bibr">36</xref>, <xref rid="B37" ref-type="bibr">37</xref>]. It is similar in structure to glucose and hence competes with glucose for transport via pancreas beta cell membrane transporter GLUT-2 and is given for the laboratory animals in a fasting state to overcome competition by glucose for entry [<xref rid="B21" ref-type="bibr">21</xref>, <xref rid="B38" ref-type="bibr">38</xref>]. Diabetes mellitus was effectively induced by administering STZ solution (150&#x02009;mg/kg) to all groups of mice. This was validated after 72 hours of STZ injection with sustained hyperglycemia.</p><p>GLC showed the antihyperglycemic effect in diabetic mice, and literature acknowledged that GLC exerts its effect by selectively blocking the ATP sensitive K<sup>+</sup> channels (K<sub>ATP</sub>) in the <italic>&#x003b2;</italic>-cells of the pancreas. Then, blockage of KATP results in the influx of Ca<sup>2+</sup> to cells which, in turn, cause depolarization in the cytosol with subsequent insulin secretion [<xref rid="B39" ref-type="bibr">39</xref>]. In this study, there was blood glucose lowering brought about by GLC-induced secretion of insulin from pancreatic <italic>&#x003b2;</italic>-cells; this indicates that a single dose of STZ at 150&#x02009;mg/kg could not cause absolute destruction of <italic>&#x003b2;</italic>-cells.</p><p>A single dose of AIRE ranging from 100&#x02009;mg/kg to 400&#x02009;mg/kg and GLC 5&#x02009;mg/kg were given to mice in the normoglycemic model. In this model, BGL of mice was reduced by different doses of hydromethanolic crude extract of <italic>Ajuga integrifolia</italic> root at the 4<sup>th</sup>&#x02009;hr and 6<sup>th</sup>&#x02009;hr compared to the baseline value, but a significant difference was not noticed. When different doses of the hydromethanolic root crude extract, baseline value, and negative control group were compared to GLC, GLC reduced the fasting BGL significantly at 2<sup>nd</sup>&#x02009;hr, 4<sup>th</sup>&#x02009;hr, and 6<sup>th</sup>&#x02009;hr. These findings are almost similar to the antidiabetic activity study reports by Belayneh and Birru [<xref rid="B23" ref-type="bibr">23</xref>].</p><p>The oral glucose tolerance test is a suitable model to measure and evaluate the insulin action and tissues sensitivity to insulin whose pancreatic release is stimulated by ingestion of glucose. It is usually used to detect persons at risk of prediabetes and diabetes [<xref rid="B39" ref-type="bibr">39</xref>, <xref rid="B40" ref-type="bibr">40</xref>]. Compared to the negative control, 100&#x02009;mg/kg AIRE did not result in a significant (<italic>p</italic> &#x0003e; 0.05) reduction of hyperglycemia at all time point except at the 2<sup>nd</sup>&#x02009;hr (120 minutes), whereas hyperglycemia was reduced significantly by GLC at the1<sup>st</sup> (<italic>p</italic> &#x0003c; 0.01) and 2<sup>nd</sup> (<italic>p</italic> &#x0003c; 0.001) hours. However, AIRE 100&#x02009;mg/kg, 200&#x02009;mg/kg, and 400&#x02009;mg/kg reduced fasting BGL approximately close to baseline and virtually similar to the GLC treated group at 120 minutes. This way modulation of blood glucose is consistent with the reports by Belayneh and Birru [<xref rid="B23" ref-type="bibr">23</xref>] and Anitha et al. [<xref rid="B41" ref-type="bibr">41</xref>]. It was evident that the BGL of mice reached its climax after 30 minutes of administration, and then, it decreased mildly at 60 minutes and reduced nearly to the normal level after 2 hours of glucose administration. The elevation of blood glucose in this pattern and its reduction at these times is consistent with the one reported by Belayneh and Birru [<xref rid="B23" ref-type="bibr">23</xref>]. This blood glucose reduction after 2 hours may be due to the glucose lowering activity of AIRE augmented by metabolic utilization of the already consumed glucose. The increased fasting BGL at 30 minutes can be explained that the glucose oral load was absorbed and reached systemic circulation by this time.</p><p>Compared to repeated daily doses at 7<sup>th</sup> day and 14<sup>th</sup> day, single dose 200&#x02009;mg/kg and 400&#x02009;mg/kg AIRE showed lesser reduction of fasting BGL at 6<sup>th</sup>&#x02009;hr and 8<sup>th</sup>&#x02009;hr supporting that the repeated daily doses of AIRE have better antidiabetic activity than the single dose. Significant reduction of fasting BGL was noticed following the repeated daily doses of AIRE after the 7<sup>th</sup> day and 14<sup>th</sup> day of treatment compared to both diabetic control and baseline. This finding is almost similar to the antidiabetic activity study reports by Belayneh and Birru [<xref rid="B23" ref-type="bibr">23</xref>, <xref rid="B27" ref-type="bibr">27</xref>]. Variation in fasting BGL was significant in normoglycemic mice at the 7<sup>th</sup> day and 14<sup>th</sup> day of the study procedure, but a significant increase in fasting BGL was seen in the diabetic control group compared to normal control and repeated daily extract doses treated groups. Compared to baseline, fasting BGL was reduced by GLC, with percentage reduction of 60.8% and 65.2% after 7<sup>th</sup> day and 14<sup>th</sup> day of treatment, respectively.</p><p>Among the solvent fractions (aqueous, chloroform, and hexane), the single dose of the aqueous fraction revealed by far the most credible antihyperglycemic activity in STZ-induced diabetic mice compared to the baseline, diabetic control groups, chloroform-treated groups, and <italic>n</italic>-hexane-treated groups. The chloroform and <italic>n</italic>-hexane fractions did not demonstrate a noticeable antihyperglycemic activity. This could suggest that common antidiabetic phytochemical constituents such as polyphenols, flavonoids, tannins, and chromium were associated to aqueous polar solvent, water, and likely to be contained in neither chloroform nor hexane [<xref rid="B13" ref-type="bibr">13</xref>, <xref rid="B18" ref-type="bibr">18</xref>].</p><p>Among the three single different doses of aqueous fractions, AQA 400&#x02009;mg/kg showed highest blood glucose lowering activity. The investigation implied that the single dose and repeated daily doses of aqueous fraction and repeated daily doses of crude extract have a comparable blood glucose lowering ability. Moreover, in repeated daily dose experiment, the GLC-treated group showed a significant reduction in BGL at 7<sup>th</sup> day and 14<sup>th</sup> day compared to groups that received various doses of aqueous fraction and crude extract of <italic>Ajuga integrifolia</italic> root. Weight loss of the mice is often associated to STZ and hyperglycaemic complication [<xref rid="B22" ref-type="bibr">22</xref>]. Compared to groups treated by both repeated daily doses of crude extract and aqueous fraction of AIRE, the bodyweight of the diabetic control group was reduced significantly after two weeks of treatment. Compared to the baseline bodyweight of the mice, there was a significant increase in bodyweight of the mice following repeated daily doses of aqueous fraction and crude extract at 14<sup>th</sup> day. The loss of bodyweight in STZ-induced diabetic mice was significantly improved by GLC (<italic>p</italic> &#x0003c; 0.05) at the 14<sup>th</sup> day of treatment compared to the diabetic control.</p><p>The antihyperglycemic activity of this medicinal herb happens as a result of biologically active phytochemicals and secondary metabolites present in the plant. These phytochemicals include phenolic compounds, alkaloids, terpenoids, flavonoids, tannins, and sterols among others. Therefore, the presence of biologically active phytochemicals may impart the blood glucose lowering effect to <italic>Ajuga integrifolia</italic> because these biologically active phytochemicals are known to lower blood glucose [<xref rid="B13" ref-type="bibr">13</xref>, <xref rid="B18" ref-type="bibr">18</xref>, <xref rid="B42" ref-type="bibr">42</xref>].</p><p>Antihyperglycemic mechanism(s) of action of <italic>Ajuga integrifolia</italic> might be attributed to potentiating of the effect of insulin either by escalating the release of insulin from <italic>&#x003b2;</italic>-cells of pancreas, increasing the utilization of glucose by peripheral tissue, reducing hepatic gluconeogenesis, inhibiting metabolic degradations of carbohydrates, or by preventing oxidative stress [<xref rid="B43" ref-type="bibr">43</xref>]. Nevertheless, the present study recommends more in-depth molecular studies to determine the precise mechanism of <italic>Ajuga integrifolia</italic> to lower blood glucose.</p></sec><sec id="sec5"><title>5. Conclusion</title><p>In the present study, adequate data were generated that uphold the claimed antihyperglycemic activity of the medicinal plant <italic>Ajuga integrifolia</italic> in the community. Hence, it can be concluded that <italic>Ajuga integrifolia</italic>, especially at 200&#x02009;mg/kg and 400&#x02009;mg/kg of bodyweight of both the crude extract and aqueous solvent fraction, is remarkably effective against STZ-induced diabetic mice models as well as in the oral glucose loaded mice models, thereby validating its ethnomedicinal usage. As far as the major finding of this investigation is concerned, <italic>Ajuga integrifolia</italic> root extract has antihyperglycemic activities. According to the findings, the use of <italic>Ajuga integrifolia</italic> for treatment of diabetes mellitus by a traditional healer is supported by this study.</p></sec></body><back><ack><title>Acknowledgments</title><p>The authors of this study thank the University of Gondar for its support.</p></ack><glossary><title>Abbreviations</title><def-list><def-item><term>ANOVA:</term><def><p>Analysis of variance</p></def></def-item><def-item><term>AIRE:</term><def><p>
<italic>Ajuga integrifolia</italic> root extract</p></def></def-item><def-item><term>BGL:</term><def><p>Blood glucose level</p></def></def-item><def-item><term>DM:</term><def><p>Diabetes mellitus</p></def></def-item><def-item><term>DW:</term><def><p>Distilled water</p></def></def-item><def-item><term>GLC:</term><def><p>Glibenclamide</p></def></def-item><def-item><term>LD50:</term><def><p>Median lethal dose</p></def></def-item><def-item><term>OECD:</term><def><p>Organization for Economic Cooperation and Development</p></def></def-item><def-item><term>STZ:</term><def><p>Streptozotocin</p></def></def-item><def-item><term>SPSS:</term><def><p>Statistical Package for Social Science</p></def></def-item><def-item><term>USD:</term><def><p>United States Dollar.</p></def></def-item></def-list></glossary><sec sec-type="data-availability"><title>Data Availability</title><p>The datasets used to support the findings of this study are available from the corresponding author upon request.</p></sec><sec><title>Ethical Approval</title><p>Ethical approval was received from the Research and Ethics Committee of Department of Pharmacology, School of Pharmacy, University of Gondar (school of pharmacy 12-112-2012). The study was conducted based on the recommendations of the Guide for the Care and Use of Laboratory Animals [<xref rid="B28" ref-type="bibr">28</xref>].</p></sec><sec sec-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare that they have no conflicts of interest.</p></sec><sec><title>Authors' Contributions</title><p>Molalegne Alene, Mohammedbrhan Abdelwuhab, Assefa Belay, and Taklo Simeneh Yazie were involved in the design and write up of the study. Molalegn Alene conducted the actual study and statistical analysis. All the authors approved the submitted version of the manuscript.</p></sec><ref-list><ref id="B1"><label>1</label><element-citation publication-type="book"><collab>WHO</collab><source><italic toggle="yes">Definition and Diagnosis of Diabetes Mellitus and Intermediate Hyperglycaemia: Report of a WHO/IDF Consultation</italic></source><year>2006</year><publisher-loc>Geneva, Switzerland</publisher-loc><publisher-name>WHO</publisher-name></element-citation></ref><ref id="B2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tiwari</surname><given-names>N.</given-names></name><name><surname>Thakur</surname><given-names>A. K.</given-names></name><name><surname>Kumar</surname><given-names>V.</given-names></name><name><surname>Dey</surname><given-names>A.</given-names></name><name><surname>Kumar</surname><given-names>V.</given-names></name></person-group><article-title>Therapeutic targets for diabetes mellitus: an update</article-title><source><italic toggle="yes">Clinical Pharmacology and Biopharmaceutic</italic></source><year>2014</year><volume>3</volume><issue>1</issue><fpage>1</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.4172/2167-065x.1000117</pub-id></element-citation></ref><ref id="B3"><label>3</label><element-citation publication-type="journal"><collab>ADA</collab><article-title>Diagnosis and classification of diabetes mellitus</article-title><source><italic toggle="yes">Diabetic Care</italic></source><year>2014</year><volume>37</volume><issue>2</issue></element-citation></ref><ref id="B4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Okur</surname><given-names>M. E.</given-names></name><name><surname>Karantas</surname><given-names>I. D.</given-names></name><name><surname>Siafaka</surname><given-names>P. I.</given-names></name></person-group><article-title>Diabetes Mellitus: a review on pathophysiology, current status of oral pathophysiology, current status of oral medications and future perspectives</article-title><source><italic toggle="yes">ACTA Pharmaceutica Sciencia</italic></source><year>2017</year><volume>55</volume><issue>1</issue><pub-id pub-id-type="doi">10.23893/1307-2080.aps.0555</pub-id><pub-id pub-id-type="other">2-s2.0-85018762400</pub-id></element-citation></ref><ref id="B5"><label>5</label><element-citation publication-type="book"><collab>International Diabetes Federation</collab><source><italic toggle="yes">Diabetes Atlas</italic></source><year>2019</year><edition>9th</edition><publisher-loc>Brussels, Belgium</publisher-loc><publisher-name>International Diabetes Federation</publisher-name><comment><ext-link ext-link-type="uri" xlink:href="https://www.diabetesatlas.org/upload/resources/2019/IDF_Atlas_9th_Edition_2019.pdf">https://www.diabetesatlas.org/upload/resources/2019/IDF_Atlas_9th_Edition_2019.pdf</ext-link></comment></element-citation></ref><ref id="B6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Piero</surname><given-names>N. M.</given-names></name><name><surname>Murugi</surname><given-names>N. J.</given-names></name><name><surname>Mwiti</surname><given-names>K. C.</given-names></name><name><surname>Mwenda</surname><given-names>M. P.</given-names></name></person-group><article-title>Pharmacological management of diabetes mellitus</article-title><source><italic toggle="yes">Asian Journal of Biochemical and Pharmaceutical Research</italic></source><year>2012</year><volume>2</volume></element-citation></ref><ref id="B7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marles</surname><given-names>R. J.</given-names></name><name><surname>Farnsworth</surname><given-names>N. R.</given-names></name></person-group><article-title>Antidiabetic plants and their active constituents</article-title><source><italic toggle="yes">Phytomedicine</italic></source><year>1995</year><volume>2</volume><issue>2</issue><fpage>137</fpage><lpage>189</lpage><pub-id pub-id-type="doi">10.1016/s0944-7113(11)80059-0</pub-id><pub-id pub-id-type="other">2-s2.0-0028835878</pub-id><pub-id pub-id-type="pmid">23196156</pub-id></element-citation></ref><ref id="B8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meresa</surname><given-names>A.</given-names></name><name><surname>Gemechu</surname><given-names>W.</given-names></name><name><surname>Basha</surname><given-names>H.</given-names></name><etal/></person-group><article-title>Herbal medicines for the management of diabetic mellitus in Ethiopia and Eretria including their phytochemical constituents</article-title><source><italic toggle="yes">American Journal of Advanced Drug Delivery</italic></source><year>2017</year><volume>5</volume><issue>1</issue><fpage>40</fpage><lpage>58</lpage><pub-id pub-id-type="doi">10.21767/2321-547x.1000011</pub-id></element-citation></ref><ref id="B9"><label>9</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Seifu</surname><given-names>A.</given-names></name></person-group><source><italic toggle="yes">Bioprospecting Potential of Ajuga Integrifolia for Access and Benefit Sharing</italic></source><year>2017</year><publisher-loc>Rome, Italy</publisher-loc><publisher-name>FAO</publisher-name></element-citation></ref><ref id="B10"><label>10</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Assefa</surname><given-names>F.</given-names></name></person-group><article-title>Antidiabetic activity of ajuga remota benth (harmegusa) leaves in streptozotocin induced diabetic rats</article-title><year>2013</year><publisher-loc>Addis Ababa, Ethiopia</publisher-loc><publisher-name>Addis Ababa University</publisher-name><comment>Thesis</comment></element-citation></ref><ref id="B11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chekole</surname><given-names>G.</given-names></name></person-group><article-title>Ethnobotanical study of medicinal plants used against human ailments in Gubalafto District, Northern Ethiopia</article-title><source><italic toggle="yes">Journal of Ethnobiology and Ethnomedicine</italic></source><year>2017</year><volume>13</volume><issue>1</issue><fpage>p. 55</fpage><pub-id pub-id-type="doi">10.1186/s13002-017-0182-7</pub-id><pub-id pub-id-type="other">2-s2.0-85030323558</pub-id><pub-id pub-id-type="pmid">28978342</pub-id></element-citation></ref><ref id="B12"><label>12</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Bekele</surname><given-names>T.</given-names></name><name><surname>Hymete</surname><given-names>A.</given-names></name><name><surname>Tadesse</surname><given-names>M.</given-names></name><name><surname>Mekonnen</surname><given-names>Y.</given-names></name></person-group><source><italic toggle="yes">Antidiabetic Activity and Phytochemical Screening of Crude Extracts of Stevia rebaudiana Bertoni and Ajuga Remota Benth Grown in Ethiopia on Alloxan-Induced Diabetic Mice</italic></source><year>2008</year><publisher-loc>Addis Ababa, Ethiopia</publisher-loc><publisher-name>Addis Ababa University</publisher-name></element-citation></ref><ref id="B13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bekeri</surname><given-names>D.</given-names></name><name><surname>Adane</surname><given-names>L.</given-names></name><name><surname>Mamo</surname><given-names>F.</given-names></name></person-group><article-title>Phytochemical investigation and isolation of compounds from ajuga integrifolia root extract</article-title><source><italic toggle="yes">World Journal of Chemistry</italic></source><year>2018</year><volume>13</volume><issue>1</issue><fpage>1</fpage><lpage>13</lpage></element-citation></ref><ref id="B14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Asmat</surname><given-names>U.</given-names></name><name><surname>Abad</surname><given-names>K.</given-names></name><name><surname>Ismail</surname><given-names>K.</given-names></name></person-group><article-title>Diabetes mellitus and oxidative stress-a concise review</article-title><source><italic toggle="yes">Saudi Pharmaceutical Journal</italic></source><year>2016</year><volume>24</volume><issue>5</issue><fpage>547</fpage><lpage>553</lpage><pub-id pub-id-type="doi">10.1016/j.jsps.2015.03.013</pub-id><pub-id pub-id-type="other">2-s2.0-84925964840</pub-id><pub-id pub-id-type="pmid">27752226</pub-id></element-citation></ref><ref id="B15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>P&#x000e9;rez-Matute</surname><given-names>P.</given-names></name><name><surname>Zulet</surname><given-names>M. A.</given-names></name><name><surname>Mart&#x000ed;nez</surname><given-names>J. A.</given-names></name></person-group><article-title>Reactive species and diabetes: counteracting oxidative stress to improve health</article-title><source><italic toggle="yes">Current Opinion in Pharmacology</italic></source><year>2009</year><volume>9</volume><issue>6</issue><fpage>771</fpage><lpage>779</lpage><pub-id pub-id-type="doi">10.1016/j.coph.2009.08.005</pub-id><pub-id pub-id-type="other">2-s2.0-70449469039</pub-id><pub-id pub-id-type="pmid">19766058</pub-id></element-citation></ref><ref id="B16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robertson</surname><given-names>R. P.</given-names></name></person-group><article-title>Chronic oxidative stress as a central mechanism for glucose toxicity in pancreatic islet beta cells in diabetes</article-title><source><italic toggle="yes">Journal of Biological Chemistry</italic></source><year>2004</year><volume>279</volume><issue>41</issue><fpage>42351</fpage><lpage>42354</lpage><pub-id pub-id-type="doi">10.1074/jbc.r400019200</pub-id><pub-id pub-id-type="other">2-s2.0-5644248079</pub-id></element-citation></ref><ref id="B17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Keshebo</surname><given-names>D. L.</given-names></name><name><surname>Washe</surname><given-names>A. P.</given-names></name><name><surname>Alemu</surname><given-names>F.</given-names></name></person-group><article-title>Determination of antimicrobial and antioxidant activities of extracts from selected medicinal plants</article-title><source><italic toggle="yes">American Scientific Research Journal for Engineering, Technology, and Sciences (ASRJETS)</italic></source><year>2016</year><volume>16</volume><issue>1</issue><fpage>212</fpage><lpage>222</lpage></element-citation></ref><ref id="B18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pala</surname><given-names>A.</given-names></name><name><surname>Jadona</surname><given-names>M.</given-names></name><name><surname>Katarea</surname><given-names>Y. K.</given-names></name><etal/></person-group><article-title>Ajuga bracteosa wall: a review on its ethnopharmacological and phytochemical studies</article-title><source><italic toggle="yes">Der Pharmacia Sinica</italic></source><year>2011</year><volume>2</volume><issue>2</issue><fpage>1</fpage><lpage>10</lpage></element-citation></ref><ref id="B19"><label>19</label><element-citation publication-type="book"><collab>OECD/OCDE</collab><source><italic toggle="yes">OECD Guideline for the Testing of Chemichals: Acute Oral Toxicity; Up-And-Down Procedure (UDP)</italic></source><year>2008</year><publisher-loc>Paris, France</publisher-loc><publisher-name>OECD</publisher-name></element-citation></ref><ref id="B20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deeds</surname><given-names>M. C.</given-names></name><name><surname>Anderson</surname><given-names>J. M.</given-names></name><name><surname>Armstrong</surname><given-names>A. S.</given-names></name><etal/></person-group><article-title>Single dose streptozotocin-induced diabetes: considerations for study design in islet transplantation models</article-title><source><italic toggle="yes">Laboratory Animals</italic></source><year>2011</year><volume>45</volume><issue>3</issue><fpage>131</fpage><lpage>140</lpage><pub-id pub-id-type="doi">10.1258/la.2010.010090</pub-id><pub-id pub-id-type="other">2-s2.0-80054695683</pub-id><pub-id pub-id-type="pmid">21478271</pub-id></element-citation></ref><ref id="B21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vital</surname><given-names>P.</given-names></name><name><surname>Larrieta</surname><given-names>E.</given-names></name><name><surname>Hiriart</surname><given-names>M.</given-names></name></person-group><article-title>Sexual dimorphism in insulin sensitivity and susceptibility to develop diabetes in rats</article-title><source><italic toggle="yes">Journal of Endocrinology</italic></source><year>2006</year><volume>190</volume><issue>2</issue><fpage>425</fpage><lpage>432</lpage><pub-id pub-id-type="doi">10.1677/joe.1.06596</pub-id><pub-id pub-id-type="other">2-s2.0-33748145697</pub-id></element-citation></ref><ref id="B22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Furman</surname><given-names>B. L.</given-names></name></person-group><article-title>Streptozotocin-induced diabetic models in mice and rats</article-title><source><italic toggle="yes">Current Protocols in Pharmacology</italic></source><year>2015</year><volume>70</volume><issue>1</issue><fpage>5</fpage><lpage>47</lpage><pub-id pub-id-type="doi">10.1002/0471141755.ph0547s70</pub-id><pub-id pub-id-type="other">2-s2.0-84963675332</pub-id></element-citation></ref><ref id="B23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Belayneh</surname><given-names>Y. M.</given-names></name><name><surname>Birru</surname><given-names>E. M.</given-names></name></person-group><article-title>Antidiabetic activities of hydromethanolic leaf extract of calpurnia aurea (ait.) benth. Subspecies aurea (fabaceae) in mice</article-title><source><italic toggle="yes">Evidence-Based Complementary and Alternative Medicine</italic></source><year>2018</year><volume>2018</volume><fpage>9</fpage><pub-id pub-id-type="publisher-id">3509073</pub-id><pub-id pub-id-type="doi">10.1155/2018/3509073</pub-id><pub-id pub-id-type="other">2-s2.0-85054018062</pub-id></element-citation></ref><ref id="B24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tafesse</surname><given-names>T. B.</given-names></name><name><surname>Hymete</surname><given-names>A.</given-names></name><name><surname>Mekonnen</surname><given-names>Y.</given-names></name><name><surname>Tadesse</surname><given-names>M.</given-names></name></person-group><article-title>Antidiabetic activity and phytochemical screening of extracts of the leaves of Ajuga remota Benth on alloxan-induced diabetic mice</article-title><source><italic toggle="yes">BMC Complementary and Alternative Medicine</italic></source><year>2017</year><volume>17</volume><issue>1</issue><fpage>1</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1186/s12906-017-1757-5</pub-id><pub-id pub-id-type="other">2-s2.0-85019003381</pub-id><pub-id pub-id-type="pmid">28049463</pub-id></element-citation></ref><ref id="B25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tamiru</surname><given-names>W.</given-names></name><name><surname>Engidawork</surname><given-names>E.</given-names></name><name><surname>Asres</surname><given-names>K.</given-names></name></person-group><article-title>Evaluation of the effects of 80% methanolic leaf extract of Caylusea abyssinica (fresen.) fisch. &#x00026; Mey. on glucose handling in normal, glucose loaded and diabetic rodents</article-title><source><italic toggle="yes">BMC Complementary and Alternative Medicine</italic></source><year>2012</year><volume>12</volume><issue>1</issue><fpage>p. 151</fpage><pub-id pub-id-type="pmid">22967092</pub-id></element-citation></ref><ref id="B26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baquer</surname><given-names>N. Z.</given-names></name><name><surname>Kumar</surname><given-names>P.</given-names></name><name><surname>Taha</surname><given-names>A.</given-names></name><name><surname>Kale</surname><given-names>R.</given-names></name><name><surname>Cowsik</surname><given-names>S.</given-names></name><name><surname>McLean</surname><given-names>P.</given-names></name></person-group><article-title>Metabolic and molecular action of Trigonella foenum-graecum (fenugreek) and trace metals in experimental diabetic tissues</article-title><source><italic toggle="yes">Journal of Biosciences</italic></source><year>2011</year><volume>36</volume><issue>2</issue><fpage>383</fpage><lpage>396</lpage><pub-id pub-id-type="doi">10.1007/s12038-011-9042-0</pub-id><pub-id pub-id-type="other">2-s2.0-80053470100</pub-id><pub-id pub-id-type="pmid">21654091</pub-id></element-citation></ref><ref id="B27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Belayneh</surname><given-names>Y. M.</given-names></name><name><surname>Birhanu</surname><given-names>Z.</given-names></name><name><surname>Birru</surname><given-names>E. M.</given-names></name><name><surname>Getenet</surname><given-names>G.</given-names></name></person-group><article-title>Evaluation of in vivo antidiabetic, antidyslipidemic, and in vitro antioxidant activities of hydromethanolic root extract of Datura stramonium L.(Solanaceae)</article-title><source><italic toggle="yes">Journal of Experimental Pharmacology</italic></source><year>2019</year><volume>11</volume><fpage>p. 29</fpage><pub-id pub-id-type="doi">10.2147/jep.s192264</pub-id><pub-id pub-id-type="other">2-s2.0-85071187830</pub-id><pub-id pub-id-type="pmid">31114400</pub-id></element-citation></ref><ref id="B28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clark</surname><given-names>J. D.</given-names></name><name><surname>Gebhart</surname><given-names>G. F.</given-names></name><name><surname>Gonder</surname><given-names>J. C.</given-names></name><name><surname>Keeling</surname><given-names>M. E.</given-names></name><name><surname>Kohn</surname><given-names>D. F.</given-names></name></person-group><article-title>The 1996 guide for the care and use of laboratory animals</article-title><source><italic toggle="yes">ILAR Journal</italic></source><year>1997</year><volume>38</volume><issue>1</issue><fpage>41</fpage><lpage>48</lpage><pub-id pub-id-type="doi">10.1093/ilar.38.1.41</pub-id><pub-id pub-id-type="pmid">11528046</pub-id></element-citation></ref><ref id="B29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sen</surname><given-names>S.</given-names></name><name><surname>Chakraborty</surname><given-names>R.</given-names></name><name><surname>Sridhar</surname><given-names>C.</given-names></name><name><surname>Reddy</surname><given-names>Y. S.</given-names></name><name><surname>De</surname><given-names>B.</given-names></name></person-group><article-title>Free radicals, antioxidants, diseases and phytomedicines: current status and future prospect</article-title><source><italic toggle="yes">International Journal of Pharmaceutical Sciences Review and Research</italic></source><year>2010</year><volume>3</volume><issue>1</issue><fpage>91</fpage><lpage>100</lpage></element-citation></ref><ref id="B30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prabhakar</surname><given-names>P. K.</given-names></name><name><surname>Doble</surname><given-names>M.</given-names></name></person-group><article-title>A target based therapeutic approach towards diabetes mellitus using medicinal plants</article-title><source><italic toggle="yes">Current Diabetes Reviews</italic></source><year>2008</year><volume>4</volume><issue>4</issue><fpage>291</fpage><lpage>308</lpage><pub-id pub-id-type="doi">10.2174/157339908786241124</pub-id><pub-id pub-id-type="other">2-s2.0-59849103075</pub-id><pub-id pub-id-type="pmid">18991598</pub-id></element-citation></ref><ref id="B31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sabu</surname><given-names>M. C.</given-names></name><name><surname>Kuttan</surname><given-names>R.</given-names></name></person-group><article-title>Anti-diabetic activity of medicinal plants and its relationship with their antioxidant property</article-title><source><italic toggle="yes">Journal of Ethnopharmacology</italic></source><year>2002</year><volume>81</volume><issue>2</issue><fpage>155</fpage><lpage>160</lpage><pub-id pub-id-type="doi">10.1016/s0378-8741(02)00034-x</pub-id><pub-id pub-id-type="other">2-s2.0-0036284599</pub-id><pub-id pub-id-type="pmid">12065146</pub-id></element-citation></ref><ref id="B32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cocquyt</surname><given-names>K.</given-names></name><name><surname>Cos</surname><given-names>P.</given-names></name><name><surname>Herdewijn</surname><given-names>P.</given-names></name><name><surname>Maes</surname><given-names>L.</given-names></name><name><surname>Van den Steen</surname><given-names>P. E.</given-names></name><name><surname>Laekeman</surname><given-names>G.</given-names></name></person-group><article-title>Ajuga remota Benth.: from ethnopharmacology to phytomedical perspective in the treatment of malaria</article-title><source><italic toggle="yes">Phytomedicine</italic></source><year>2011</year><volume>18</volume><issue>14</issue><fpage>1229</fpage><lpage>1237</lpage><pub-id pub-id-type="doi">10.1016/j.phymed.2011.08.063</pub-id><pub-id pub-id-type="other">2-s2.0-80155190085</pub-id><pub-id pub-id-type="pmid">22015320</pub-id></element-citation></ref><ref id="B33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>El Hilaly</surname><given-names>J.</given-names></name><name><surname>Lyoussi</surname><given-names>B.</given-names></name></person-group><article-title>Hypoglycaemic effect of the lyophilised aqueous extract of Ajuga iva in normal and streptozotocin diabetic rats</article-title><source><italic toggle="yes">Journal of Ethnopharmacology</italic></source><year>2002</year><volume>80</volume><issue>2-3</issue><fpage>109</fpage><lpage>113</lpage><pub-id pub-id-type="doi">10.1016/s0378-8741(01)00407-x</pub-id><pub-id pub-id-type="other">2-s2.0-0036238318</pub-id><pub-id pub-id-type="pmid">12007699</pub-id></element-citation></ref><ref id="B34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hailu</surname><given-names>W.</given-names></name><name><surname>Engidawork</surname><given-names>E.</given-names></name></person-group><article-title>Evaluation of the diuretic activity of the aqueous and 80% methanol extracts of Ajuga remota Benth (Lamiaceae) leaves in mice</article-title><source><italic toggle="yes">BMC Complementary and Alternative Medicine</italic></source><year>2014</year><volume>14</volume><issue>1</issue><fpage>p. 135</fpage><pub-id pub-id-type="doi">10.1186/1472-6882-14-135</pub-id><pub-id pub-id-type="other">2-s2.0-84899487134</pub-id><pub-id pub-id-type="pmid">24720845</pub-id></element-citation></ref><ref id="B35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Radenkovi&#x00107;</surname><given-names>M.</given-names></name><name><surname>Stojanovi&#x00107;</surname><given-names>M.</given-names></name><name><surname>Prostran</surname><given-names>M.</given-names></name></person-group><article-title>Experimental diabetes induced by alloxan and streptozotocin: the current state of the art</article-title><source><italic toggle="yes">Journal of Pharmacological and Toxicological Methods</italic></source><year>2016</year><volume>78</volume><fpage>13</fpage><lpage>31</lpage><pub-id pub-id-type="pmid">26596652</pub-id></element-citation></ref><ref id="B36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Etuk</surname><given-names>E. U.</given-names></name></person-group><article-title>Animals models for studying diabetes mellitus</article-title><source><italic toggle="yes">Agriculture and Biology Journal of North America</italic></source><year>2010</year><volume>1</volume><issue>2</issue><fpage>130</fpage><lpage>134</lpage></element-citation></ref><ref id="B37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rees</surname><given-names>D. A.</given-names></name><name><surname>Alcolado</surname><given-names>J. C.</given-names></name></person-group><article-title>Animal models of diabetes mellitus</article-title><source><italic toggle="yes">Diabetic Medicine</italic></source><year>2005</year><volume>22</volume><issue>4</issue><fpage>359</fpage><lpage>370</lpage><pub-id pub-id-type="doi">10.1111/j.1464-5491.2005.01499.x</pub-id><pub-id pub-id-type="other">2-s2.0-17144404203</pub-id><pub-id pub-id-type="pmid">15787657</pub-id></element-citation></ref><ref id="B38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hilakivi-Clarke</surname><given-names>L. A.</given-names></name><name><surname>Wozniak</surname><given-names>K. M.</given-names></name><name><surname>Durcan</surname><given-names>M. J.</given-names></name><name><surname>Linnoila</surname><given-names>M.</given-names></name></person-group><article-title>Behavior of streptozotocin-diabetic mice in tests of exploration, locomotion, anxiety, depression and aggression</article-title><source><italic toggle="yes">Physiology &#x00026; Behavior</italic></source><year>1990</year><volume>48</volume><issue>3</issue><fpage>429</fpage><lpage>433</lpage><pub-id pub-id-type="doi">10.1016/0031-9384(90)90339-6</pub-id><pub-id pub-id-type="other">2-s2.0-0025085741</pub-id><pub-id pub-id-type="pmid">2148392</pub-id></element-citation></ref><ref id="B39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Malaisse-Lagae</surname><given-names>F. R.</given-names></name><name><surname>Malaisse</surname><given-names>W. J.</given-names></name></person-group><article-title>Stimulus-secretion coupling of glucose-induced insulin release. III. Uptake of <sup>45</sup>calcium by isolated islets of Langerhans</article-title><source><italic toggle="yes">Endocrinology</italic></source><year>1971</year><volume>88</volume><issue>1</issue><fpage>72</fpage><lpage>80</lpage><pub-id pub-id-type="doi">10.1210/endo-88-1-72</pub-id><pub-id pub-id-type="other">2-s2.0-0014986741</pub-id><pub-id pub-id-type="pmid">4921884</pub-id></element-citation></ref><ref id="B40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andrikopoulos</surname><given-names>S.</given-names></name><name><surname>Blair</surname><given-names>A. R.</given-names></name><name><surname>Deluca</surname><given-names>N.</given-names></name><name><surname>Fam</surname><given-names>B. C.</given-names></name><name><surname>Proietto</surname><given-names>J.</given-names></name></person-group><article-title>Evaluating the glucose tolerance test in mice</article-title><source><italic toggle="yes">American Journal of Physiology-Endocrinology and Metabolism</italic></source><year>2008</year><volume>295</volume><issue>6</issue><fpage>E1323</fpage><lpage>E1332</lpage><pub-id pub-id-type="doi">10.1152/ajpendo.90617.2008</pub-id><pub-id pub-id-type="other">2-s2.0-57349179133</pub-id><pub-id pub-id-type="pmid">18812462</pub-id></element-citation></ref><ref id="B41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anitha</surname><given-names>M.</given-names></name><name><surname>Sakthidevi</surname><given-names>G.</given-names></name><name><surname>Muthukumarasamy</surname><given-names>S.</given-names></name><name><surname>Mohan</surname><given-names>V. R.</given-names></name></person-group><article-title>Effect of Cynoglossum zeylanicum (Vehl ex Hornem) Thunb. ex Lehm on oral glucose tolerance in rats</article-title><source><italic toggle="yes">Journal of Applied Pharmaceutical Science</italic></source><year>2012</year><volume>2</volume><issue>11</issue><fpage>p. 75</fpage><pub-id pub-id-type="doi">10.7324/japs.2012.21113</pub-id><pub-id pub-id-type="other">2-s2.0-84876024222</pub-id></element-citation></ref><ref id="B42"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prabhakar</surname><given-names>P. K.</given-names></name><name><surname>Doble</surname><given-names>M. U.</given-names></name></person-group><article-title>Mechanism of action of medicinal plants towards diabetes mellitus-a review</article-title><source><italic toggle="yes">Recent Progress in Medicinal Plants</italic></source><year>2008</year><volume>22</volume><fpage>181</fpage><lpage>204</lpage></element-citation></ref><ref id="B43"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jung</surname><given-names>M.</given-names></name><name><surname>Park</surname><given-names>M.</given-names></name><name><surname>Lee</surname><given-names>H. C.</given-names></name><name><surname>Kang</surname><given-names>Y. H.</given-names></name><name><surname>Kang</surname><given-names>E. S.</given-names></name><name><surname>Kim</surname><given-names>S. K.</given-names></name></person-group><article-title>Antidiabetic agents from medicinal plants</article-title><source><italic toggle="yes">Current Medicinal Chemistry</italic></source><year>2006</year><volume>13</volume><issue>10</issue><fpage>1203</fpage><lpage>1218</lpage><pub-id pub-id-type="doi">10.2174/092986706776360860</pub-id><pub-id pub-id-type="other">2-s2.0-33645979959</pub-id><pub-id pub-id-type="pmid">16719780</pub-id></element-citation></ref></ref-list></back><floats-group><table-wrap id="tab1" orientation="portrait" position="float"><label>Table 1</label><caption><p>Hypoglycemic activity of AIR crude extract in normoglycemic mice.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" colspan="6" rowspan="1">Blood glucose level (mg/dl)</th></tr><tr><th align="left" rowspan="1" colspan="1">Group</th><th align="center" rowspan="1" colspan="1">0&#x02009;hr</th><th align="center" rowspan="1" colspan="1">1&#x02009;hr</th><th align="center" rowspan="1" colspan="1">2&#x02009;hr</th><th align="center" rowspan="1" colspan="1">4&#x02009;hr</th><th align="center" rowspan="1" colspan="1">6&#x02009;hr</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">DW10&#x02009;mg/kg</td><td align="center" rowspan="1" colspan="1">70.60&#x02009;&#x000b1;&#x02009;0.707</td><td align="center" rowspan="1" colspan="1">69.40&#x02009;&#x000b1;&#x02009;1.208</td><td align="center" rowspan="1" colspan="1">71.20&#x02009;&#x000b1;&#x02009;2.131</td><td align="center" rowspan="1" colspan="1">72.40&#x02009;&#x000b1;&#x02009;1.860</td><td align="center" rowspan="1" colspan="1">68.60&#x02009;&#x000b1;&#x02009;1.304</td></tr><tr><td align="left" rowspan="1" colspan="1">AIRE100&#x02009;mg/kg</td><td align="center" rowspan="1" colspan="1">74.00&#x02009;&#x000b1;&#x02009;2.449</td><td align="center" rowspan="1" colspan="1">75.40&#x02009;&#x000b1;&#x02009;2.135</td><td align="center" rowspan="1" colspan="1">74.80&#x02009;&#x000b1;&#x02009;1.503</td><td align="center" rowspan="1" colspan="1">69.20&#x02009;&#x000b1;&#x02009;2.634</td><td align="center" rowspan="1" colspan="1">67.80&#x02009;&#x000b1;&#x02009;2.088</td></tr><tr><td align="left" rowspan="1" colspan="1">AIRE200&#x02009;mg/kg</td><td align="center" rowspan="1" colspan="1">69.60&#x02009;&#x000b1;&#x02009;1.208</td><td align="center" rowspan="1" colspan="1">69.60&#x02009;&#x000b1;&#x02009;1.503</td><td align="center" rowspan="1" colspan="1">70.60&#x02009;&#x000b1;&#x02009;0.872</td><td align="center" rowspan="1" colspan="1">67.20&#x02009;&#x000b1;&#x02009;0.860</td><td align="center" rowspan="1" colspan="1">68.40&#x02009;&#x000b1;&#x02009;1.581</td></tr><tr><td align="left" rowspan="1" colspan="1">AIRE400&#x02009;mg/kg</td><td align="center" rowspan="1" colspan="1">72.60&#x02009;&#x000b1;&#x02009;1.568</td><td align="center" rowspan="1" colspan="1">72.90&#x02009;&#x000b1;&#x02009;1.001</td><td align="center" rowspan="1" colspan="1">73.80&#x02009;&#x000b1;&#x02009;2.267</td><td align="center" rowspan="1" colspan="1">69.10&#x02009;&#x000b1;&#x02009;1.778</td><td align="center" rowspan="1" colspan="1">66.20&#x02009;&#x000b1;&#x02009;1.631</td></tr><tr><td align="left" rowspan="1" colspan="1">GLC 5&#x02009;mg/kg</td><td align="center" rowspan="1" colspan="1">72.40&#x02009;&#x000b1;&#x02009;1.560</td><td align="center" rowspan="1" colspan="1">55.80&#x02009;&#x000b1;&#x02009;2.985</td><td align="center" rowspan="1" colspan="1">51.60&#x02009;&#x000b1;&#x02009;2.272<sup>a1b1c1d1<italic>&#x003b2;</italic>1</sup></td><td align="center" rowspan="1" colspan="1">43.60&#x02009;&#x000b1;&#x02009;1.568<sup>AzBxCxDx<italic>&#x003b2;</italic>y</sup></td><td align="center" rowspan="1" colspan="1">36.60&#x02009;&#x000b1;&#x02009;1.965<sup>AzByCyDy<italic>&#x003b2;</italic>z</sup></td></tr></tbody></table><table-wrap-foot><fn><p>
<italic>N</italic>&#x02009;=&#x02009;6 for each treatment; each value is presented in mean&#x02009;&#x000b1;&#x02009;SEM. <sup>A</sup>Compared to the negative control; <sup><italic>&#x003b2;</italic></sup>compared to the baseline blood glucose level; <sup>B</sup>compared to 100&#x02009;mg/kg AIRE; <sup>C</sup>compared to 200&#x02009;mg/kg AIRE; <sup>D</sup>compared to 400&#x02009;mg/kg AIRE. &#x02009;<sup>X</sup><italic>p</italic> &#x0003c; 0.05;<sup>y</sup><italic>p</italic> &#x0003c; 0.01; &#x02009;<sup>z</sup><italic>p</italic> &#x0003c; 0.001. AIRE, <italic>Ajuga integrifolia</italic> root extract; DW, distilled water; GLC, glibenclamide.</p></fn></table-wrap-foot></table-wrap><table-wrap id="tab2" orientation="portrait" position="float"><label>Table 2</label><caption><p>Oral glucose tolerance test of crude root extract of <italic>Ajuga integrifolia</italic> in the oral glucose loaded mice model.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" colspan="5" rowspan="1">Blood glucose level (mg/dl)</th></tr><tr><th align="left" rowspan="1" colspan="1">Group</th><th align="center" rowspan="1" colspan="1">0&#x02009;min</th><th align="center" rowspan="1" colspan="1">30&#x02009;min</th><th align="center" rowspan="1" colspan="1">60&#x02009;min</th><th align="center" rowspan="1" colspan="1">120&#x02009;min</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">DW10&#x02009;ml/kg</td><td align="center" rowspan="1" colspan="1">82.8&#x02009;&#x000b1;&#x02009;2.634</td><td align="center" rowspan="1" colspan="1">214.6&#x02009;&#x000b1;&#x02009;5.802<sup><italic>&#x003b2;</italic>z</sup></td><td align="center" rowspan="1" colspan="1">157.8&#x02009;&#x000b1;&#x02009;4.164<sup><italic>&#x003b2;</italic>z3x</sup></td><td align="center" rowspan="1" colspan="1">113.8&#x02009;&#x000b1;&#x02009;4.974<sup>3z</sup></td></tr><tr><td align="left" rowspan="1" colspan="1">AIRE100&#x02009;mg/kg</td><td align="center" rowspan="1" colspan="1">87.6&#x02009;&#x000b1;&#x02009;2.249</td><td align="center" rowspan="1" colspan="1">211.2&#x02009;&#x000b1;&#x02009;4.994<sup><italic>&#x003b2;</italic>z</sup></td><td align="center" rowspan="1" colspan="1">148.8&#x02009;&#x000b1;&#x02009;4.944<sup><italic>&#x003b2;</italic>z3y</sup></td><td align="center" rowspan="1" colspan="1">89.8&#x02009;&#x000b1;&#x02009;2.437<sup>Ax3z</sup></td></tr><tr><td align="left" rowspan="1" colspan="1">AIRE200&#x02009;mg/kg</td><td align="center" rowspan="1" colspan="1">82.6&#x02009;&#x000b1;&#x02009;2.731</td><td align="center" rowspan="1" colspan="1">205.6&#x02009;&#x000b1;&#x02009;5.820<sup>Ax<italic>&#x003b2;</italic>z</sup></td><td align="center" rowspan="1" colspan="1">148.6&#x02009;&#x000b1;&#x02009;5.573<sup>Ax<italic>&#x003b2;</italic>z3y</sup></td><td align="center" rowspan="1" colspan="1">88&#x02009;&#x000b1;&#x02009;2.530 5<sup>AxBx3z</sup></td></tr><tr><td align="left" rowspan="1" colspan="1">AIRE400&#x02009;mg/kg</td><td align="center" rowspan="1" colspan="1">73.8&#x02009;&#x000b1;&#x02009;1.625</td><td align="center" rowspan="1" colspan="1">212.6&#x02009;&#x000b1;&#x02009;7.852<sup>Ax<italic>&#x003b2;</italic>z</sup></td><td align="center" rowspan="1" colspan="1">142.8&#x02009;&#x000b1;&#x02009;3.105<sup>Ax<italic>&#x003b2;</italic>z3z</sup></td><td align="center" rowspan="1" colspan="1">79.6&#x02009;&#x000b1;&#x02009;4.98<sup>AyBxCx3z</sup></td></tr><tr><td align="left" rowspan="1" colspan="1">GLC5&#x02009;mg/kg</td><td align="center" rowspan="1" colspan="1">76&#x02009;&#x000b1;&#x02009;2.408</td><td align="center" rowspan="1" colspan="1">154.4&#x02009;&#x000b1;&#x02009;7.461<sup>AyByCyDy<italic>&#x003b2;</italic>z</sup></td><td align="center" rowspan="1" colspan="1">73.6&#x02009;&#x000b1;&#x02009;5.112<sup>AzByCyDy<italic>&#x003b2;</italic>z3y</sup></td><td align="center" rowspan="1" colspan="1">61.8&#x02009;&#x000b1;&#x02009;6.715<sup>AxBxCxDx<italic>&#x003b2;</italic>z3z</sup></td></tr></tbody></table><table-wrap-foot><fn><p>
<italic>N</italic>&#x02009;=&#x02009;6 for each treatment; each value is presented in mean&#x02009;&#x000b1;&#x02009;SEM. <sup>A</sup>Compared to the negative control; <sup><italic>&#x003b2;</italic></sup>compared to the baseline blood glucose level; <sup>B</sup>compared to 100&#x02009;mg/kg AIRE; <sup>C</sup>compared to 200&#x02009;mg/kg AIRE; <sup>D</sup>compared to 400&#x02009;mg/kg AIRE; <sup>3</sup>compared to the blood glucose level at 30 minute. &#x02009;<sup>x</sup><italic>p</italic> &#x0003c; 0.05;<sup>y</sup><italic>p</italic> &#x0003c; 0.01; &#x02009;<sup>z</sup><italic>p</italic> &#x0003c; 0.001. DW, distilled water; AIRE, <italic>Ajuga integrifolia</italic> root extract; GLC, glibenclamide. Time in minute indicates after oral glucose load.</p></fn></table-wrap-foot></table-wrap><table-wrap id="tab3" orientation="portrait" position="float"><label>Table 3</label><caption><p>Effect of single dose AIRE on hyperglycemia in STZ-induced diabetic mice.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" colspan="6" rowspan="1">Blood glucose level (mg/dl)</th></tr><tr><th align="left" rowspan="1" colspan="1">Group</th><th align="center" rowspan="1" colspan="1">0&#x02009;hr</th><th align="center" rowspan="1" colspan="1">2&#x02009;hr</th><th align="center" rowspan="1" colspan="1">4&#x02009;hr</th><th align="center" rowspan="1" colspan="1">6&#x02009;hr</th><th align="center" rowspan="1" colspan="1">8&#x02009;hr</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">DW10&#x02009;ml/kg</td><td align="center" rowspan="1" colspan="1">391.6&#x02009;&#x000b1;&#x02009;2.249</td><td align="center" rowspan="1" colspan="1">386.2&#x02009;&#x000b1;&#x02009;5.877</td><td align="center" rowspan="1" colspan="1">395&#x02009;&#x000b1;&#x02009;1.581</td><td align="center" rowspan="1" colspan="1">393.8&#x02009;&#x000b1;&#x02009;1.497</td><td align="center" rowspan="1" colspan="1">395.4&#x02009;&#x000b1;&#x02009;1.600</td></tr><tr><td align="left" rowspan="1" colspan="1">AIRE100&#x02009;mg/kg</td><td align="center" rowspan="1" colspan="1">416&#x02009;&#x000b1;&#x02009;27.817</td><td align="center" rowspan="1" colspan="1">382&#x02009;&#x000b1;&#x02009;19.514</td><td align="center" rowspan="1" colspan="1">365&#x02009;&#x000b1;&#x02009;10.124</td><td align="center" rowspan="1" colspan="1">369&#x02009;&#x000b1;&#x02009;9.894</td><td align="center" rowspan="1" colspan="1">253&#x02009;&#x000b1;&#x02009;9.160<sup>Ax<italic>&#x003b2;</italic>y</sup></td></tr><tr><td align="left" rowspan="1" colspan="1">AIRE200&#x02009;mg/kg</td><td align="center" rowspan="1" colspan="1">377.4&#x02009;&#x000b1;&#x02009;21.970</td><td align="center" rowspan="1" colspan="1">358.4&#x02009;&#x000b1;&#x02009;18.10</td><td align="center" rowspan="1" colspan="1">343.6&#x02009;&#x000b1;&#x02009;16.336</td><td align="center" rowspan="1" colspan="1">339.2&#x02009;&#x000b1;&#x02009;12.816</td><td align="center" rowspan="1" colspan="1">317.6&#x02009;&#x000b1;&#x02009;10.671<sup>AxBx<italic>&#x003b2;</italic>y</sup></td></tr><tr><td align="left" rowspan="1" colspan="1">AIRE400&#x02009;mg/kg</td><td align="center" rowspan="1" colspan="1">393&#x02009;&#x000b1;&#x02009;11.176</td><td align="center" rowspan="1" colspan="1">368.6&#x02009;&#x000b1;&#x02009;14.038</td><td align="center" rowspan="1" colspan="1">362&#x02009;&#x000b1;&#x02009;17.283</td><td align="center" rowspan="1" colspan="1">349.2&#x02009;&#x000b1;&#x02009;19.523</td><td align="center" rowspan="1" colspan="1">313.4&#x02009;&#x000b1;&#x02009;8.897<sup>AxBx<italic>&#x003b2;</italic>y</sup></td></tr><tr><td align="left" rowspan="1" colspan="1">GLC&#x02009;mg/kg</td><td align="center" rowspan="1" colspan="1">376.4&#x02009;&#x000b1;&#x02009;8.698</td><td align="center" rowspan="1" colspan="1">282.6&#x02009;&#x000b1;&#x02009;2.960<sup>Ax<italic>&#x003b2;</italic>y</sup></td><td align="center" rowspan="1" colspan="1">197.2&#x02009;&#x000b1;&#x02009;4.224<sup>Ax<italic>&#x003b2;</italic>z</sup></td><td align="center" rowspan="1" colspan="1">178.2&#x02009;&#x000b1;&#x02009;2.653<sup>AyBxCxDx<italic>&#x003b2;</italic>z</sup></td><td align="center" rowspan="1" colspan="1">168&#x02009;&#x000b1;&#x02009;3.975<sup>az bxcxdx<italic>&#x003b2;</italic>z</sup></td></tr></tbody></table><table-wrap-foot><fn><p>
<italic>N</italic>&#x02009;=&#x02009;6 for each treatment; each value is presented in mean&#x02009;&#x000b1;&#x02009;SEM. <sup>A</sup>Compared to the negative control; <sup><italic>&#x003b2;</italic></sup>compared to the baseline blood glucose level; <sup>B</sup>compared to 100&#x02009;mg/kg AIRE; <sup>C</sup>compared to 200&#x02009;mg/kg AIRE; <sup>D</sup>compared to 400&#x02009;mg/kg AIRE. &#x02009;<sup>x</sup><italic>p</italic> &#x0003c; 0.05;<sup>y</sup><italic>p</italic> &#x0003c; 0.01; &#x02009;<sup>z</sup><italic>p</italic> &#x0003c; 0.001. DW, distilled water; GLC, glibenclamide; AIRE, <italic>Ajuga integrifolia</italic> root extract.</p></fn></table-wrap-foot></table-wrap><table-wrap id="tab4" orientation="portrait" position="float"><label>Table 4</label><caption><p>The activity of repeated daily doses of crude extract of AIRE on hyperglycemia in STZ-induced diabetic mice.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" colspan="6" rowspan="1">Blood glucose level (mg/dl)</th></tr><tr><th align="left" rowspan="1" colspan="1">Group</th><th align="center" rowspan="1" colspan="1">FBGL at baseline</th><th align="center" rowspan="1" colspan="1">FBGL after 7 days</th><th align="center" rowspan="1" colspan="1">FBGL after 14 days</th><th align="center" rowspan="1" colspan="1">
<italic>R</italic> (%) at 7 days</th><th align="center" rowspan="1" colspan="1">
<italic>R</italic> (%) at 14 days</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">DW10&#x02009;ml/kg</td><td align="center" rowspan="1" colspan="1">391.6&#x02009;&#x000b1;&#x02009;2.249</td><td align="center" rowspan="1" colspan="1">393.8&#x02009;&#x000b1;&#x02009;1.967</td><td align="center" rowspan="1" colspan="1">397.6&#x02009;&#x000b1;&#x02009;4.226</td><td align="center" rowspan="1" colspan="1">&#x02212;0.56</td><td align="center" rowspan="1" colspan="1">&#x02212;1.50</td></tr><tr><td align="left" rowspan="1" colspan="1">AIRE100&#x02009;mg/kg</td><td align="center" rowspan="1" colspan="1">416&#x02009;&#x000b1;&#x02009;27.817</td><td align="center" rowspan="1" colspan="1">349.4&#x02009;&#x000b1;&#x02009;17.657<sup>Ax<italic>&#x003b2;</italic>znx</sup></td><td align="center" rowspan="1" colspan="1">338.9&#x02009;&#x000b1;&#x02009;19.530<sup>Ax<italic>&#x003b2;</italic>znx</sup></td><td align="center" rowspan="1" colspan="1">16.10</td><td align="center" rowspan="1" colspan="1">18.50</td></tr><tr><td align="left" rowspan="1" colspan="1">AIRE200&#x02009;mg/kg</td><td align="center" rowspan="1" colspan="1">377.4&#x02009;&#x000b1;&#x02009;21.970</td><td align="center" rowspan="1" colspan="1">296.6&#x02009;&#x000b1;&#x02009;11.369<sup>Ax<italic>&#x003b2;</italic>znx</sup></td><td align="center" rowspan="1" colspan="1">284.4&#x02009;&#x000b1;&#x02009;4.760<sup>Ay<italic>&#x003b2;</italic>znx</sup></td><td align="center" rowspan="1" colspan="1">21.40</td><td align="center" rowspan="1" colspan="1">24.60</td></tr><tr><td align="left" rowspan="1" colspan="1">AIRE400&#x02009;mg/kg</td><td align="center" rowspan="1" colspan="1">393&#x02009;&#x000b1;&#x02009;11.176</td><td align="center" rowspan="1" colspan="1">288.5&#x02009;&#x000b1;&#x02009;9.963<sup>Ax<italic>&#x003b2;</italic>zny</sup></td><td align="center" rowspan="1" colspan="1">279.8&#x02009;&#x000b1;&#x02009;10.856<sup>Ax<italic>&#x003b2;</italic>zny</sup></td><td align="center" rowspan="1" colspan="1">26.50</td><td align="center" rowspan="1" colspan="1">28.80</td></tr><tr><td align="left" rowspan="1" colspan="1">GLC5&#x02009;mg/kg</td><td align="center" rowspan="1" colspan="1">376.4&#x02009;&#x000b1;&#x02009;8.698</td><td align="center" rowspan="1" colspan="1">147.2&#x02009;&#x000b1;&#x02009;3.056<sup>AyByCxDx<italic>&#x003b2;</italic>yny</sup></td><td align="center" rowspan="1" colspan="1">129.4&#x02009;&#x000b1;&#x02009;3.429<sup>AzByCxDx<italic>&#x003b2;</italic>zny</sup></td><td align="center" rowspan="1" colspan="1">60.80</td><td align="center" rowspan="1" colspan="1">65.60</td></tr><tr><td align="left" rowspan="1" colspan="1">Normal control</td><td align="center" rowspan="1" colspan="1">77.6&#x02009;&#x000b1;&#x02009;7.987</td><td align="center" rowspan="1" colspan="1">77.4&#x02009;&#x000b1;&#x02009;2.966</td><td align="center" rowspan="1" colspan="1">77.2&#x02009;&#x000b1;&#x02009;1.815</td><td align="center" rowspan="1" colspan="1">0.25</td><td align="center" rowspan="1" colspan="1">0.51</td></tr></tbody></table><table-wrap-foot><fn><p>
<italic>N</italic>&#x02009;=&#x02009;6 for each treatment; each value is presented in mean&#x02009;&#x000b1;&#x02009;SEM. <sup>A</sup>Compared to diabetic control; <sup><italic>&#x003b2;</italic></sup>compared to the baseline blood glucose level; <sup>B</sup>compared to 100&#x02009;mg/kg AIRE; <sup>C</sup>compared to 200&#x02009;mg/kg AIRE; <sup>D</sup>compared to 400&#x02009;mg/kg AIRE; <sup>n</sup>compared to normal control. &#x02009;<sup>x</sup><italic>p</italic> &#x0003c; 0.05;<sup>y</sup><italic>p</italic> &#x0003c; 0.01; &#x02009;<sup>z</sup><italic>p</italic> &#x0003c; 0.001. DW, distilled water; GLC, glibenclamide; AIRE, <italic>Ajuga integrifolia</italic> root extract; R, reduction.</p></fn></table-wrap-foot></table-wrap><table-wrap id="tab5" orientation="portrait" position="float"><label>Table 5</label><caption><p>The effect of repeated daily doses of <italic>Ajuga integrifolia</italic> root extract on bodyweight in STZ-induced diabetic mice.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" colspan="5" rowspan="1">Bodyweight (gram)</th></tr><tr><th align="left" rowspan="1" colspan="1">Group</th><th align="center" rowspan="1" colspan="1">Before induction</th><th align="center" rowspan="1" colspan="1">Baseline</th><th align="center" rowspan="1" colspan="1">7 days after t/t</th><th align="center" rowspan="1" colspan="1">14 days after t/t</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">DW 10&#x02009;ml/kg</td><td align="center" rowspan="1" colspan="1">29.80&#x02009;&#x000b1;&#x02009;1.251</td><td align="center" rowspan="1" colspan="1">27.31&#x02009;&#x000b1;&#x02009;1.140</td><td align="center" rowspan="1" colspan="1">25.75&#x02009;&#x000b1;&#x02009;1.900</td><td align="center" rowspan="1" colspan="1">23.09&#x02009;&#x000b1;&#x02009;1.371</td></tr><tr><td align="left" rowspan="1" colspan="1">AIRE 100&#x02009;mg/kg</td><td align="center" rowspan="1" colspan="1">28.25&#x02009;&#x000b1;&#x02009;1.89</td><td align="center" rowspan="1" colspan="1">26.84&#x02009;&#x000b1;&#x02009;2.331</td><td align="center" rowspan="1" colspan="1">25.92&#x02009;&#x000b1;&#x02009;2.170</td><td align="center" rowspan="1" colspan="1">24.74&#x02009;&#x000b1;&#x02009;1.382</td></tr><tr><td align="left" rowspan="1" colspan="1">AIRE 200&#x02009;mg/kg</td><td align="center" rowspan="1" colspan="1">27.92&#x02009;&#x000b1;&#x02009;2.71</td><td align="center" rowspan="1" colspan="1">25.62&#x02009;&#x000b1;&#x02009;2.120</td><td align="center" rowspan="1" colspan="1">26.53&#x02009;&#x000b1;&#x02009;1.070<sup>Ax<italic>&#x003b2;</italic>ynx</sup></td><td align="center" rowspan="1" colspan="1">26.33&#x02009;&#x000b1;&#x02009;1.080<sup>Ay<italic>&#x003b2;</italic>znx</sup></td></tr><tr><td align="left" rowspan="1" colspan="1">AIRE400&#x02009;mg/kg</td><td align="center" rowspan="1" colspan="1">28.10&#x02009;&#x000b1;&#x02009;2.092</td><td align="center" rowspan="1" colspan="1">26.90&#x02009;&#x000b1;&#x02009;1.220</td><td align="center" rowspan="1" colspan="1">27.25&#x02009;&#x000b1;&#x02009;1.320<sup>Ax<italic>&#x003b2;</italic>ynx</sup></td><td align="center" rowspan="1" colspan="1">27.6&#x02009;&#x000b1;&#x02009;1.684<sup>Ay<italic>&#x003b2;</italic>znx</sup></td></tr><tr><td align="left" rowspan="1" colspan="1">GLC5&#x02009;mg/kg</td><td align="center" rowspan="1" colspan="1">26.80&#x02009;&#x000b1;&#x02009;1.631</td><td align="center" rowspan="1" colspan="1">25.71&#x02009;&#x000b1;&#x02009;1.933</td><td align="center" rowspan="1" colspan="1">27.48&#x02009;&#x000b1;&#x02009;2.124<sup>Ay<italic>&#x003b2;</italic>znx</sup></td><td align="center" rowspan="1" colspan="1">27.90&#x02009;&#x000b1;&#x02009;2.153<sup>Az<italic>&#x003b2;</italic>znx</sup></td></tr><tr><td align="left" rowspan="1" colspan="1">Normal control</td><td align="center" rowspan="1" colspan="1">30.40&#x02009;&#x000b1;&#x02009;2.360</td><td align="center" rowspan="1" colspan="1">29.53&#x02009;&#x000b1;&#x02009;2.730</td><td align="center" rowspan="1" colspan="1">30.10&#x02009;&#x000b1;&#x02009;1.552</td><td align="center" rowspan="1" colspan="1">29.53&#x02009;&#x000b1;&#x02009;1.447</td></tr></tbody></table><table-wrap-foot><fn><p>
<italic>N</italic>&#x02009;=&#x02009;6 for each treatment; each value is presented in mean&#x02009;&#x000b1;&#x02009;SEM. <sup>A</sup>Compared to the diabetic control; <sup><italic>&#x003b2;</italic></sup>compared to the baseline blood glucose level; <sup>B</sup>compared to 100&#x02009;mg/kg AIRE; <sup>C</sup>compared to 200&#x02009;mg/kg AIRE; <sup>D</sup>compared to 400&#x02009;mg/kg AIRE; <sup><italic>n</italic></sup>compared to normal control. &#x02009;<sup>x</sup><italic>p</italic> &#x0003c; 0.05;<sup>y</sup><italic>p</italic> &#x0003c; 0.01; &#x02009;<sup>z</sup><italic>p</italic> &#x0003c; 0.001. DW, distilled water; GLC, glibenclamide; AIRE, <italic>Ajuga integrifolia</italic> root extract; t/t, treatment.</p></fn></table-wrap-foot></table-wrap><table-wrap id="tab6" orientation="portrait" position="float"><label>Table 6</label><caption><p>The activity of single doses of three fractions of AIRE on hyperglycemia in STZ-induced diabetic mice.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" colspan="6" rowspan="1">Blood glucose level (mg/dl)</th></tr><tr><th align="left" rowspan="1" colspan="1">Group</th><th align="center" rowspan="1" colspan="1">0&#x02009;hr</th><th align="center" rowspan="1" colspan="1">2&#x02009;hr</th><th align="center" rowspan="1" colspan="1">4&#x02009;hr</th><th align="center" rowspan="1" colspan="1">6&#x02009;hr</th><th align="center" rowspan="1" colspan="1">8&#x02009;hr</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">DW10&#x02009;ml/kg</td><td align="center" rowspan="1" colspan="1">391.6&#x02009;&#x000b1;&#x02009;5.03</td><td align="center" rowspan="1" colspan="1">393.2&#x02009;&#x000b1;&#x02009;3.023</td><td align="center" rowspan="1" colspan="1">391.6&#x02009;&#x000b1;&#x02009;4.261</td><td align="center" rowspan="1" colspan="1">388.6&#x02009;&#x000b1;&#x02009;3.487</td><td align="center" rowspan="1" colspan="1">391.8&#x02009;&#x000b1;&#x02009;2.223</td></tr><tr><td align="left" rowspan="1" colspan="1">AQA100&#x02009;mg/kg</td><td align="center" rowspan="1" colspan="1">415.8&#x02009;&#x000b1;&#x02009;62.311</td><td align="center" rowspan="1" colspan="1">396&#x02009;&#x000b1;&#x02009;34.095</td><td align="center" rowspan="1" colspan="1">401.6&#x02009;&#x000b1;&#x02009;10.870</td><td align="center" rowspan="1" colspan="1">394&#x02009;&#x000b1;&#x02009;5.621</td><td align="center" rowspan="1" colspan="1">388.4&#x02009;&#x000b1;&#x02009;27.817</td></tr><tr><td align="left" rowspan="1" colspan="1">AQA200&#x02009;mg/kg</td><td align="center" rowspan="1" colspan="1">375.4&#x02009;&#x000b1;&#x02009;52.600</td><td align="center" rowspan="1" colspan="1">336.2&#x02009;&#x000b1;&#x02009;22.030</td><td align="center" rowspan="1" colspan="1">316.8&#x02009;&#x000b1;&#x02009;21.224</td><td align="center" rowspan="1" colspan="1">323.4&#x02009;&#x000b1;&#x02009;19.065</td><td align="center" rowspan="1" colspan="1">312.7&#x02009;&#x000b1;&#x02009;23.376<sup>AxCxHx<italic>&#x003b2;</italic>x</sup></td></tr><tr><td align="left" rowspan="1" colspan="1">AQA400&#x02009;mg/kg</td><td align="center" rowspan="1" colspan="1">393&#x02009;&#x000b1;&#x02009;24.900</td><td align="center" rowspan="1" colspan="1">354.2&#x02009;&#x000b1;&#x02009;18.940</td><td align="center" rowspan="1" colspan="1">359.4&#x02009;&#x000b1;&#x02009;10.539</td><td align="center" rowspan="1" colspan="1">334.6&#x02009;&#x000b1;&#x02009;7.004</td><td align="center" rowspan="1" colspan="1">309.8&#x02009;&#x000b1;&#x02009;5.643<sup>AxCxHx<italic>&#x003b2;</italic>x</sup></td></tr><tr><td align="left" rowspan="1" colspan="1">HX100&#x02009;mg/kg</td><td align="center" rowspan="1" colspan="1">376.4&#x02009;&#x000b1;&#x02009;8.698</td><td align="center" rowspan="1" colspan="1">384.8&#x02009;&#x000b1;&#x02009;5.526</td><td align="center" rowspan="1" colspan="1">372.4&#x02009;&#x000b1;&#x02009;14.590</td><td align="center" rowspan="1" colspan="1">370&#x02009;&#x000b1;&#x02009;9.560</td><td align="center" rowspan="1" colspan="1">377.8&#x02009;&#x000b1;&#x02009;11.508</td></tr><tr><td align="left" rowspan="1" colspan="1">HX200&#x02009;mg/kg</td><td align="center" rowspan="1" colspan="1">387&#x02009;&#x000b1;&#x02009;12.892</td><td align="center" rowspan="1" colspan="1">373.2&#x02009;&#x000b1;&#x02009;16.451</td><td align="center" rowspan="1" colspan="1">399.4&#x02009;&#x000b1;&#x02009;11.830</td><td align="center" rowspan="1" colspan="1">413&#x02009;&#x000b1;&#x02009;16.257</td><td align="center" rowspan="1" colspan="1">378.6&#x02009;&#x000b1;&#x02009;10.722</td></tr><tr><td align="left" rowspan="1" colspan="1">HX400&#x02009;mg/kg</td><td align="center" rowspan="1" colspan="1">395.6&#x02009;&#x000b1;&#x02009;15.045</td><td align="center" rowspan="1" colspan="1">421.2&#x02009;&#x000b1;&#x02009;16.488</td><td align="center" rowspan="1" colspan="1">418.6&#x02009;&#x000b1;&#x02009;11.927</td><td align="center" rowspan="1" colspan="1">394.2&#x02009;&#x000b1;&#x02009;5.544</td><td align="center" rowspan="1" colspan="1">430.4&#x02009;&#x000b1;&#x02009;24.330</td></tr><tr><td align="left" rowspan="1" colspan="1">CHL100&#x02009;mg/kg</td><td align="center" rowspan="1" colspan="1">385.8&#x02009;&#x000b1;&#x02009;8.470</td><td align="center" rowspan="1" colspan="1">388.2&#x02009;&#x000b1;&#x02009;3.917</td><td align="center" rowspan="1" colspan="1">399&#x02009;&#x000b1;&#x02009;9.365</td><td align="center" rowspan="1" colspan="1">390.2&#x02009;&#x000b1;&#x02009;15.160</td><td align="center" rowspan="1" colspan="1">397.2&#x02009;&#x000b1;&#x02009;9.754</td></tr><tr><td align="left" rowspan="1" colspan="1">CHL200&#x02009;mg/kg</td><td align="center" rowspan="1" colspan="1">394.2&#x02009;&#x000b1;&#x02009;8.381</td><td align="center" rowspan="1" colspan="1">405.2&#x02009;&#x000b1;&#x02009;17.080</td><td align="center" rowspan="1" colspan="1">407.8&#x02009;&#x000b1;&#x02009;24.800</td><td align="center" rowspan="1" colspan="1">418.6&#x02009;&#x000b1;&#x02009;13.851</td><td align="center" rowspan="1" colspan="1">401.2&#x02009;&#x000b1;&#x02009;11.770</td></tr><tr><td align="left" rowspan="1" colspan="1">CHL400&#x02009;mg/kg</td><td align="center" rowspan="1" colspan="1">386.8&#x02009;&#x000b1;&#x02009;7.179</td><td align="center" rowspan="1" colspan="1">380.2&#x02009;&#x000b1;&#x02009;5.324</td><td align="center" rowspan="1" colspan="1">306&#x02009;&#x000b1;&#x02009;12.779</td><td align="center" rowspan="1" colspan="1">406.4&#x02009;&#x000b1;&#x02009;8.334</td><td align="center" rowspan="1" colspan="1">387.8&#x02009;&#x000b1;&#x02009;4.375</td></tr><tr><td align="left" rowspan="1" colspan="1">GBC5&#x02009;mg/kg</td><td align="center" rowspan="1" colspan="1">376.4&#x02009;&#x000b1;&#x02009;19.450</td><td align="center" rowspan="1" colspan="1">292.6&#x02009;&#x000b1;&#x02009;8.004<sup>Ax<italic>&#x003b2;</italic>x</sup></td><td align="center" rowspan="1" colspan="1">240.9&#x02009;&#x000b1;&#x02009;8.213<sup>Ax<italic>&#x003b2;</italic>x</sup></td><td align="center" rowspan="1" colspan="1">199.2&#x02009;&#x000b1;&#x02009;8.399<sup>Ay<italic>&#x003b2;</italic>y</sup></td><td align="center" rowspan="1" colspan="1">134.6&#x02009;&#x000b1;&#x02009;3.842<sup>Az<italic>&#x003b2;</italic>z</sup></td></tr></tbody></table><table-wrap-foot><fn><p>
<italic>N</italic>&#x02009;=&#x02009;6 for each treatment group; each value is presented in mean&#x02009;&#x000b1;&#x02009;SEM. <sup>A</sup>Compared to negative control; <sup><italic>&#x003b2;</italic></sup>compared to baseline; <sup>B</sup>compared to 100&#x02009;mg/kg; <sup>C</sup>compared to chloroform; <sup>H</sup>compared to hexane. &#x02009;<sup>x</sup><italic>p</italic> &#x0003c; 0.05;<sup>y</sup><italic>p</italic> &#x0003c; 0.01; &#x02009;<sup>z</sup><italic>p</italic> &#x0003c; 0.001. AQA, aqueous; HX, hexane; CH, chloroform; GLC, glibenclamide.</p></fn></table-wrap-foot></table-wrap><table-wrap id="tab7" orientation="portrait" position="float"><label>Table 7</label><caption><p>The activity of repeated daily doses of aqueous fraction of AIRE against hyperglycemia in STZ-induced diabetic mice.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" colspan="6" rowspan="1">Blood glucose level (mg/dl)</th></tr><tr><th align="left" rowspan="1" colspan="1">Group</th><th align="center" rowspan="1" colspan="1">Baseline BGL</th><th align="center" rowspan="1" colspan="1">BGL at 7<sup>th</sup> day</th><th align="center" rowspan="1" colspan="1">BGL at 14<sup>th</sup> day</th><th align="center" rowspan="1" colspan="1">7<sup>th</sup> day <italic>R</italic> (%)</th><th align="center" rowspan="1" colspan="1">14<sup>th</sup> day <italic>R</italic> (%)</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">DW10&#x02009;ml/kg</td><td align="center" rowspan="1" colspan="1">391.6&#x02009;&#x000b1;&#x02009;5.030</td><td align="center" rowspan="1" colspan="1">429.2&#x02009;&#x000b1;&#x02009;33.041</td><td align="center" rowspan="1" colspan="1">489.2&#x02009;&#x000b1;&#x02009;43.101</td><td align="center" rowspan="1" colspan="1">&#x02212;9.58</td><td align="center" rowspan="1" colspan="1">&#x02212;24.85</td></tr><tr><td align="left" rowspan="1" colspan="1">AQA100&#x02009;mg/kg</td><td align="center" rowspan="1" colspan="1">415.8&#x02009;&#x000b1;&#x02009;62.311</td><td align="center" rowspan="1" colspan="1">379.19&#x02009;&#x000b1;&#x02009;25.203<sup>Ax<italic>&#x003b2;</italic>xnx</sup></td><td align="center" rowspan="1" colspan="1">372.8&#x02009;&#x000b1;&#x02009;26.329<sup>Ax<italic>&#x003b2;</italic>xnx</sup></td><td align="center" rowspan="1" colspan="1">7.93</td><td align="center" rowspan="1" colspan="1">9.43</td></tr><tr><td align="left" rowspan="1" colspan="1">AQA200&#x02009;mg/kg</td><td align="center" rowspan="1" colspan="1">375.4&#x02009;&#x000b1;&#x02009;52.681</td><td align="center" rowspan="1" colspan="1">311.20&#x02009;&#x000b1;&#x02009;35.181<sup>AyBx<italic>&#x003b2;</italic>xnx</sup></td><td align="center" rowspan="1" colspan="1">296.2&#x02009;&#x000b1;&#x02009;36.093<sup>AyBx<italic>&#x003b2;</italic>xnx</sup></td><td align="center" rowspan="1" colspan="1">16.76</td><td align="center" rowspan="1" colspan="1">20.52</td></tr><tr><td align="left" rowspan="1" colspan="1">AQA400&#x02009;mg/kg</td><td align="center" rowspan="1" colspan="1">393&#x02009;&#x000b1;&#x02009;24.990</td><td align="center" rowspan="1" colspan="1">306.21&#x02009;&#x000b1;&#x02009;20.584<sup>AyBx<italic>&#x003b2;</italic>xnx</sup></td><td align="center" rowspan="1" colspan="1">286&#x02009;&#x000b1;&#x02009;21.91<sup>AyBx<italic>&#x003b2;</italic>xnx</sup></td><td align="center" rowspan="1" colspan="1">22.13</td><td align="center" rowspan="1" colspan="1">23.89</td></tr><tr><td align="left" rowspan="1" colspan="1">GLC5&#x02009;mg/kg</td><td align="center" rowspan="1" colspan="1">376.4&#x02009;&#x000b1;&#x02009;19.45</td><td align="center" rowspan="1" colspan="1">146.6&#x02009;&#x000b1;&#x02009;16.607<sup>AyBzCxDy <italic>&#x003b2;</italic>ynx</sup></td><td align="center" rowspan="1" colspan="1">135.2&#x02009;&#x000b1;&#x02009;6.907 <sup>AzBzCyDy<italic>&#x003b2;</italic>zn1</sup></td><td align="center" rowspan="1" colspan="1">61.3.0</td><td align="center" rowspan="1" colspan="1">64.10</td></tr><tr><td align="left" rowspan="1" colspan="1">Normal control</td><td align="center" rowspan="1" colspan="1">82.6&#x02009;&#x000b1;&#x02009;4.231</td><td align="center" rowspan="1" colspan="1">81.9&#x02009;&#x000b1;&#x02009;2.890</td><td align="center" rowspan="1" colspan="1">82.8&#x02009;&#x000b1;&#x02009;1.931</td><td align="center" rowspan="1" colspan="1">0.840</td><td align="center" rowspan="1" colspan="1">&#x02212;0.20</td></tr></tbody></table><table-wrap-foot><fn><p>
<italic>N</italic>&#x02009;=&#x02009;6 for each group; each value is presented in mean&#x02009;&#x000b1;&#x02009;SEM. <sup>A</sup>Compared to diabetic control; <sup><italic>&#x003b2;</italic></sup>compared to baseline; <sup>B</sup>compared to 100&#x02009;mg/kg; <sup>C</sup>compared to 200&#x02009;mg/kg; <sup>D</sup>compared to 400&#x02009;mg/kg; <sup>n</sup>compared to normal control. &#x02009;<sup>x</sup><italic>p</italic> &#x0003c; 0.05;<sup>y</sup><italic>p</italic> &#x0003c; 0.01; &#x02009;<sup>z</sup><italic>p</italic> &#x0003c; 0.001. GLC, glibenclamide; AQA, aqueous; DW, distilled water; <italic>R</italic>, reduction.</p></fn></table-wrap-foot></table-wrap><table-wrap id="tab8" orientation="portrait" position="float"><label>Table 8</label><caption><p>Effect of repeated daily doses of aqueous fraction of AIR on bodyweight in STZ-induced diabetic mice.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" colspan="5" rowspan="1">Bodyweight (gram)</th></tr><tr><th align="left" rowspan="1" colspan="1">Group</th><th align="center" rowspan="1" colspan="1">Before induction</th><th align="center" rowspan="1" colspan="1">Baseline</th><th align="center" rowspan="1" colspan="1">After 7 days</th><th align="center" rowspan="1" colspan="1">After 14 days</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">DW10&#x02009;ml/kg</td><td align="center" rowspan="1" colspan="1">29.34&#x02009;&#x000b1;&#x02009;1.516</td><td align="center" rowspan="1" colspan="1">26.4&#x02009;&#x000b1;&#x02009;0.894</td><td align="center" rowspan="1" colspan="1">23&#x02009;&#x000b1;&#x02009;2.915<sup>Gx<italic>&#x003b2;</italic>xnxBxCxDx</sup></td><td align="center" rowspan="1" colspan="1">21.2&#x02009;&#x000b1;&#x02009;1.781<sup>Gx<italic>&#x003b2;</italic>xnxBxCxDx</sup></td></tr><tr><td align="left" rowspan="1" colspan="1">AIRE100&#x02009;mg/kg</td><td align="center" rowspan="1" colspan="1">30.8&#x02009;&#x000b1;&#x02009;3.271</td><td align="center" rowspan="1" colspan="1">26.6&#x02009;&#x000b1;&#x02009;2.074</td><td align="center" rowspan="1" colspan="1">25.3&#x02009;&#x000b1;&#x02009;1.732</td><td align="center" rowspan="1" colspan="1">26.2&#x02009;&#x000b1;&#x02009;1.924</td></tr><tr><td align="left" rowspan="1" colspan="1">AIRE200&#x02009;mg/kg</td><td align="center" rowspan="1" colspan="1">27&#x02009;&#x000b1;&#x02009;2.739</td><td align="center" rowspan="1" colspan="1">24.2&#x02009;&#x000b1;&#x02009;1.924</td><td align="center" rowspan="1" colspan="1">24.8&#x02009;&#x000b1;&#x02009;2.550<sup><italic>&#x003b2;</italic>x</sup></td><td align="center" rowspan="1" colspan="1">25.4&#x02009;&#x000b1;&#x02009;2.387<sup><italic>&#x003b2;</italic>x</sup></td></tr><tr><td align="left" rowspan="1" colspan="1">AIRE400&#x02009;mg/kg</td><td align="center" rowspan="1" colspan="1">27.4&#x02009;&#x000b1;&#x02009;2.074</td><td align="center" rowspan="1" colspan="1">25.3&#x02009;&#x000b1;&#x02009;1.673</td><td align="center" rowspan="1" colspan="1">25.6&#x02009;&#x000b1;&#x02009;1.817<sup><italic>&#x003b2;</italic>x</sup></td><td align="center" rowspan="1" colspan="1">26.9.&#x02009;&#x000b1;&#x02009;1.789<sup><italic>&#x003b2;</italic>x</sup></td></tr><tr><td align="left" rowspan="1" colspan="1">GLC5&#x02009;mg/kg</td><td align="center" rowspan="1" colspan="1">28.4&#x02009;&#x000b1;&#x02009;4.615</td><td align="center" rowspan="1" colspan="1">26.8&#x02009;&#x000b1;&#x02009;1.789</td><td align="center" rowspan="1" colspan="1">27.84&#x02009;&#x000b1;&#x02009;1.483</td><td align="center" rowspan="1" colspan="1">28.7&#x02009;&#x000b1;&#x02009;1.516<sup><italic>&#x003b2;</italic>x</sup></td></tr><tr><td align="left" rowspan="1" colspan="1">Normal control</td><td align="center" rowspan="1" colspan="1">28.2&#x02009;&#x000b1;&#x02009;3.033</td><td align="center" rowspan="1" colspan="1">28.9&#x02009;&#x000b1;&#x02009;2.302</td><td align="center" rowspan="1" colspan="1">29&#x02009;&#x000b1;&#x02009;2.121</td><td align="center" rowspan="1" colspan="1">29.4&#x02009;&#x000b1;&#x02009;2.074</td></tr></tbody></table><table-wrap-foot><fn><p>
<italic>N</italic>&#x02009;=&#x02009;6 for each group; each value is presented in mean&#x02009;&#x000b1;&#x02009;SEM. <sup>G</sup>Compared to 5&#x02009;mg/kg GLC; <sup><italic>&#x003b2;</italic></sup>compared to the baseline value; <sup>B</sup>compared to 100&#x02009;mg/kg AIRE; <sup>C</sup>compared to 200&#x02009;mg/kg; <sup>D</sup>compared to 400&#x02009;mg/kg AIRE; <sup>n</sup>compared to normal control. &#x02009;<sup>x</sup><italic>p</italic>=0.05. AIRE, <italic>Ajuga integrifolia</italic> root extract; GLC, glibenclamide; DW, distilled water.</p></fn></table-wrap-foot></table-wrap></floats-group></article>